EP3397206B1 - Atrial pocket closures for prosthetic heart valves - Google Patents
Atrial pocket closures for prosthetic heart valves Download PDFInfo
- Publication number
- EP3397206B1 EP3397206B1 EP16828858.7A EP16828858A EP3397206B1 EP 3397206 B1 EP3397206 B1 EP 3397206B1 EP 16828858 A EP16828858 A EP 16828858A EP 3397206 B1 EP3397206 B1 EP 3397206B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- outer frame
- inner frame
- frame
- valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003709 heart valve Anatomy 0.000 title claims description 90
- 230000001746 atrial effect Effects 0.000 title description 12
- 239000000463 material Substances 0.000 claims description 66
- 238000010168 coupling process Methods 0.000 claims description 44
- 230000008878 coupling Effects 0.000 claims description 42
- 238000005859 coupling reaction Methods 0.000 claims description 42
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 16
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 15
- 208000007536 Thrombosis Diseases 0.000 claims description 14
- 210000001015 abdomen Anatomy 0.000 claims description 8
- 210000003743 erythrocyte Anatomy 0.000 claims description 8
- 230000000717 retained effect Effects 0.000 claims description 5
- 239000012781 shape memory material Substances 0.000 claims description 3
- 210000002837 heart atrium Anatomy 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 16
- 210000004115 mitral valve Anatomy 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 238000013459 approach Methods 0.000 description 12
- 229920000728 polyester Polymers 0.000 description 8
- 210000005246 left atrium Anatomy 0.000 description 7
- 229910045601 alloy Inorganic materials 0.000 description 6
- 239000000956 alloy Substances 0.000 description 6
- 238000004873 anchoring Methods 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 150000002739 metals Chemical class 0.000 description 6
- 210000003516 pericardium Anatomy 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 229910000734 martensite Inorganic materials 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229910018507 Al—Ni Inorganic materials 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 206010053567 Coagulopathies Diseases 0.000 description 3
- 229910017535 Cu-Al-Ni Inorganic materials 0.000 description 3
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 3
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- 230000035602 clotting Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 3
- 241000283073 Equus caballus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 210000003157 atrial septum Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229920001692 polycarbonate urethane Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- -1 polytetrafluoroethylene Polymers 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940053363 periguard Drugs 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940068917 polyethylene glycols Drugs 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 210000000591 tricuspid valve Anatomy 0.000 description 1
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0057—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof stretchable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0091—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements connected by a hinged linkage mechanism, e.g. of the single-bar or multi-bar linkage type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0034—D-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0069—Sealing means
Definitions
- Prosthetic heart valves including those for insertion into atrioventricular valves (tricuspid and mitral valves) are susceptible to various problems, including problems with insufficient articulation and sealing of the valve within the native valve annulus, pulmonary edema due to poor atrial drainage, perivalvular leaking around the install prosthetic valve, lack of a good fit for the prosthetic valve within the native valve annulus, atrial tissue erosion, excess wear on the Nitinol structures, interference with the aorta at the anterior side of the mitral annulus, lack of customization, and thrombus formation, to name a few. Accordingly, there is a need for a prosthetic heart valve that can address some or all of these problems.
- a prosthetic heart valve that can have an expanded configuration for implantation within the heart and a collapsed or compressed configuration that has a sufficiently small outer perimeter or diameter to allow the prosthetic heart valve to be placed in a relatively small delivery catheter or sheath.
- a prosthetic heart valve it is also desirable for features of the prosthetic heart valve, such as those described above, to be maintained.
- WO 2014/210124 A1 describes a prosthetic heart valve which may include an outer support assembly, an inner valve assembly, which define between them an annular space, and a pocket closure that bounds the annular space to form a pocket in which thrombus can be formed and retained.
- US 2015/0327995 A1 describes a prosthetic heart valve including a collapsible and expandable stent extending from an inflow end to an outflow end and a plurality of prosthetic valve leaflets coupled to the stent.
- the prosthetic heart valve may also include a sealing ring coupled to the inflow end of the stent, the sealing ring comprising a tube extending circumferentially around the inflow end of the stent.
- WO 2015/120122 A2 describes apparatus and methods for use in the transfemoral delivery and deployment of a prosthetic mitral valve, wherein a method may include inverting an outer frame of a prosthetic mitral valve when in a biased expanded configuration.
- WO 2014/144937 A2 describes prosthetic heart valve devices for pay cutaneous replacement of native heart valves and associated systems and methods, wherein a prosthetic heart valve device may include an anchoring member having an upstream portion configured to engage with tissue on or near the annulus of the native heart valve and to deform in a non-circular shape to conform to the tissue.
- the device can also include a mechanically isolated valve support coupled to the anchoring member and configured to support a prosthetic valve.
- the prosthetic heart valve includes an outer frame coupled to an inner frame such that the outer frame can be moved between a first position relative to the inner frame and a second position relative to the inner frame in which the outer frame is inverted relative to the inner frame.
- the inner frame and the outer frame define between them an annular space.
- a pocket closure bounds the annular space to form a pocket in which thrombus can form and be retained.
- the pocket closure can include a stretchable pocket covering that can move from a first position in which the pocket covering has a first length when the outer frame is in the first position relative to the inner frame and a second position in which the pocket covering has a second length greater than the first length when the outer frame is in the second position relative to the inner frame.
- Prosthetic heart valves are described herein that include an outer frame coupled to an inner frame.
- the outer frame and the inner frame define between them an annular space, and a pocket closure bounds the annular space to form a pocket in which thrombus can form and be retained.
- a prosthetic heart valve includes an outer frame coupled to an inner frame such that the outer frame can be moved between a first position relative to the inner frame and a second position relative to the inner frame in which the outer frame is inverted relative to the inner frame.
- the pocket closure can include a stretchable pocket covering that can move from a first position in which the pocket covering has a first length when the outer frame is in the first position relative to the inner frame and a second position in which the pocket covering has a second length greater than the first length when the outer frame is in the second position relative to the inner frame.
- prosthetic heart valves described herein can be configured to be moved to an inverted configuration for delivery of the prosthetic valve to within a heart of a patient.
- a prosthetic valve includes an outer frame that can be inverted relative to an inner frame when the prosthetic valve is in a biased expanded configuration.
- the prosthetic mitral valve can be formed with, for example, a shape-memory material. After inverting the outer frame, the prosthetic valve can be inserted into a lumen of a delivery sheath such that the prosthetic valve is moved to a collapsed configuration.
- the delivery sheath can be used to deliver an inverted prosthetic valve as described herein to within a patient's heart using a variety of different delivery approaches for delivering a prosthetic heart valve (e.g., prosthetic mitral valve) where the inverted prosthetic valve would enter the heart through the atrium of the heart.
- a prosthetic heart valve e.g., prosthetic mitral valve
- the prosthetic valves described herein can be delivered using a transfemoral delivery approach as described in International Application No. PCT/US15/14572 (the '572 PCT application) published as WO2015120122 A2 , above or via a transatrial approach, such as described in U.S. Provisional Patent Application Serial No.
- an inverted valve as described herein could be delivered via a transjugular approach, via the right atrium and through the atrial septum and into the left atrium, as described in the '221 application.
- the prosthetic valves described herein can also be delivered apically if desired. After the delivery sheath has been disposed within the left atrium of the heart, the prosthetic mitral valve is moved distally out of the delivery sheath such that the inverted outer frame reverts and the prosthetic valve assumes its biased expanded configuration. The prosthetic mitral valve can then be positioned within a mitral annulus of the heart.
- FIGS. 1A and 1B A schematic representation of a prosthetic heart valve 100 is shown in FIGS. 1A and 1B .
- Prosthetic heart valve 100 (also referred to as “prosthetic valve” or “valve”) is designed to replace a damaged or diseased native heart valve such as a mitral valve.
- Valve 100 includes an outer frame assembly 110 and an inner valve assembly 140 that is coupled to the outer frame assembly.
- outer fame assembly 110 may be formed of an outer frame 120, and can be covered on all or a portion of its outer face with an outer covering (not shown), and covered on all or a portion of its inner face by an inner covering (not shown).
- An embodiment of a prosthetic valve showing the inner and outer coverings is described below with respect to FIGS. 3-5 .
- the outer frame assembly 110 can include a covering on only an outer face or only an inner face of the outer frame 120. In some embodiments, there can be more than one layer of covering on the inner face and/or the outer face of the outer frame 120.
- the inner and outer coverings of the outer frame assembly 110 can completely cover the inner face and/or outer face of the outer frame 120 or can partially cover the inner face and/or the outer face of the outer frame 120.
- the outer frame assembly 110 may not include a covering on the inner face or the outer face of the outer frame 120.
- the outer frame assembly 110 can include no material or covering on an inner face of the outer frame 120 and two layers or coverings disposed on an outer face of the outer frame 120.
- a first layer or covering can be, for example, a tissue that fully covers the outer face of the outer frame 120 and the outermost layer or covering can be a thin polyester that covers only a portion of the outer frame 120.
- the outermost covering can cover one or two rows of cells of a cuff portion of the outer frame 120.
- Outer frame 120 can provide several functions for prosthetic heart valve 100, including serving as the primary structure, as an anchoring mechanism and/or an attachment point for a separate anchoring mechanism to anchor the valve to the native heart valve apparatus, a support to carry inner valve assembly 140, and/or a seal to inhibit paravalvular leakage between prosthetic heart valve 100 and the native heart valve apparatus.
- Outer frame 120 is preferably formed so that it can be deformed (compressed and/or expanded) and, when released, return to its original (undeformed) shape.
- outer frame 120 is preferably formed of materials, such as metals or plastics, that have shape memory properties.
- metals Nitinol ® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic.
- Other shape memory alloys such as Cu-Zn-Al-Ni alloys, and Cu-Al-Ni alloys, may be used.
- Outer frame 120 is preferably formed from a laser cut, thin-walled tube of Nitinol ® .
- the laser cuts form regular cutouts in the thin Nitinol ® tube.
- the tube can be expanded radially, placed on a mold or mandrel of the desired shape, heated to the martensitic temperature, and quenched.
- the treatment of the frame in this manner will form an open lattice frame structure, and may have a flared end or cuff at the atrium end portion 116 of outer frame 120.
- Outer frame 120 thus has shape memory properties and will readily revert to the memory shape at the calibrated temperature.
- outer frame 120 may be constructed from braided wire or other suitable material.
- Inner valve assembly 140 is shown schematically in more detail in FIGS. 2A-2C .
- Inner valve assembly 140 can include an inner frame 150, an outer covering 160, and leaflets 170.
- inner frame 150 includes six axial posts or frame members that support outer covering 160 and leaflets 170.
- Leaflets 170 are attached along three of the posts, shown as commissure posts 152 in FIG. 2A
- outer covering 160 is attached to the other three posts, 154 in FIG. 2A , and optionally to commissure posts 152.
- the outer covering 160 can be attached to an inner face of the inner frame 150 or to an outer face of the inner frame 150. As shown schematically in FIG.
- each of outer covering 160 and leaflets 170 are formed of approximately rectangular sheets of material, which are joined together at their upper, or atrium end.
- the lower, ventricle end of outer covering 160 may be joined to the inner covering (not shown) of outer frame assembly 110 (not shown in FIG. 2A ), and the lower, ventricle end of leaflets 170 may form free edges, though coupled to the lower ends of commissure posts 152.
- the covering 160 and leaflets 170 can be formed from a single rectangular sheet of material, then folded over and trimmed to the shape of the inner frame, staying connected at the top of the inner frame where the material is folded over.
- the covering 160 and/or the leaflets 170 can be formed from material having a shape other than rectangular, such as from a semi-circular piece of material, or can be laser cut to the shape of the inner frame.
- leaflets 170 are movable between a first or open configuration ( FIG. 2B ), and a second or closed configuration ( FIG. 2C ) in which the leaflets 170 coapt, or meet in sealing abutment.
- leaflets 170 may have a smaller outer perimeter than outer covering 160.
- the free lower edges of the leaflets 170, between commissure posts 152 are spaced radially from the lower edge of outer covering 160. This radial spacing facilitates movement of the leaflets from the open position in FIG. 2B to the closed position in FIG. 2C , as the counter flow of blood from the ventricle to the atrium during systole can catch the free edges of the bellies and push the leaflets closed.
- the outer covering and the inner covering of outer frame assembly 110, outer covering 160 and leaflets 170 may be formed of any suitable material, or combination of materials.
- the outer covering and the inner covering of outer frame assembly 110, outer covering 160 and leaflets 170 may be formed of a tissue.
- the tissue is optionally a biological tissue, such as a chemically stabilized tissue from a heart valve of an animal, such as a pig, or pericardial tissue of an animal, such as cow (bovine pericardium) or sheep (ovine pericardium) or pig (porcine pericardium) or horse (equine pericardium).
- valve leaflets 170 may optionally be made from pericardial tissue or small intestine submucosal tissue.
- Synthetic materials such as polyurethane or polytetrafluoroethylene, may also be used for valve leaflets 170.
- synthetic polymer materials such as, for example, expanded polytetrafluoroethylene or polyester may optionally be used.
- suitable materials may optionally include thermoplastic polycarbonate urethane, polyether urethane, segmented polyether urethane, silicone polyether urethane, silicone-polycarbonate urethane, and ultra-high molecular weight polyethylene.
- Additional biocompatible polymers may optionally include polyolefins, elastomers, polyethyleneglycols, polyethersulphones, polysulphones, polyvinylpyrrolidones, polyvinylchlorides, other fluoropolymers, silicone polyesters, siloxane polymers and/or oligomers, and/or polylactones, and block co-polymers using the same.
- valve leaflets 170 may optionally have a surface that has been treated with (or reacted with) an anti-coagulant, such as, without limitation, immobilized heparin.
- an anti-coagulant such as, without limitation, immobilized heparin.
- inner valve assembly 140 may be substantially cylindrical, and outer frame assembly 110 may be tapered, extending from a smaller diameter (slightly larger than the outer diameter of inner valve assembly 140) at a lower, ventricle portion 112 (where it is coupled to inner valve assembly 140) to a larger diameter, atrium portion 116, with an intermediate diameter, annulus portion 114 between the atrium and ventricle portions, 112 and 116, respectively.
- a tapered annular space or pocket 185 (also referred to herein as "atrial pocket”) is thus formed between the outer surface of inner valve assembly 140 and the inner surface of outer frame assembly 110, open to the atrium end of valve assembly 100.
- blood from the atrium can move in and out of pocket 185.
- the blood can clot, forming thrombus.
- the pocket can be covered, or enclosed, by a pocket closure 180 (also referred to as an "atrial pocket closure").
- Pocket closure 180 can be formed at least in part of any suitable material that is sufficiently porous to allow blood, including particularly red blood cells, to enter pocket 185, but is not so porous as to allow undesirably large thrombi to leave the pocket 185.
- pocket closure 180 may be formed at least in part from a woven or knit polyester fabric with apertures less than 160 ⁇ , and preferably between 90 ⁇ and 120 ⁇ .
- the pocket closure 180 can be formed at least in part from a braided Nitinol material that has a desired porosity.
- the pocket closure 180 can be formed at least in part from a braided tubular Nitinol material.
- pocket closure 180 it is not necessary for the entirety of pocket closure 180 to be formed of the same material, with the same porosity.
- some portions of pocket closure 180 may be formed of a less porous, or blood impermeable, material and other portions formed of material of the porosity range noted above.
- a portion of the outer frame assembly 110 or the inner valve assembly 140 may be formed with an aperture that communicates with pocket 180, covered by a closure formed of material having the desired porosity, thus providing another path by which blood may enter, but thrombi are prevented from leaving, atrial pocket 185.
- inner valve assembly 110 and/or the inner surface of outer frame assembly 140, need not by circular in cross-section as shown schematically in FIGS. 1A and 1B , but may be of non-constant radius at a given location along the central axis of valve 100.
- pocket 185 may not be of constant cross-section, and may not be continuous, but rather may be formed in two or more fluidically isolated, partially annular volumes.
- pocket closure 180 need not be shaped as a ring with constant width as shown schematically in FIGS. 1A and 1B , but rather can be a continuous ring of varying with, a more complicated continuous shape, or may be formed in multiple, discrete sections.
- the pocket closure 180 can be formed as a tubular member defining an interior region.
- Pocket closure 180 serves to trap and/or slow the flow of blood within pocket 185, which can increase formation and retention of thrombus in pocket 185. It also promotes active in-growth of native tissue into the several coverings of prosthetic heart valve 100, further stabilizing valve 100 in the native heart valve.
- the material forming the outer covering of inner valve assembly 140 can also be hardened or stiffened, providing better support for leaflets 170.
- a mass of thrombus filling pocket 185 can serve as potting for inner valve assembly 140, further stabilizing the valve assembly. Greater stability for inner valve assembly 140 can provide more reliable coaption of valve leaflets 170, and thus more effective performance.
- the mass of thrombus can also stabilize the outer frame assembly 110 after it has been installed in, and flexibly conformed to, the native valve apparatus. This can provide a more effective seal between prosthetic heart valve 100 and the native valve apparatus, and reduce perivalvular leakage.
- FIGS. 3-5 are front, bottom, and top views, respectively, of a prosthetic heart valve 200 according to an embodiment.
- Prosthetic heart valve 200 (also referred to herein as “valve” or “prosthetic valve”) is designed to replace a damaged or diseased native heart valve such as a mitral valve.
- Valve 200 includes an outer frame assembly 210 and an inner valve assembly 240 coupled to the outer frame assembly 210.
- outer frame assembly 210 includes an outer frame 220, covered on all or a portion of its outer face with an outer covering 230, and covered on all or a portion of its inner face by an inner covering 232.
- Outer frame 220 can provide several functions for prosthetic heart valve 200, including serving as the primary structure, as an anchoring mechanism and/or an attachment point for a separate anchoring mechanism to anchor the valve to the native heart valve apparatus, a support to carry inner valve assembly 240, and/or a seal to inhibit paravalvular leakage between prosthetic heart valve 200 and the native heart valve apparatus.
- Outer frame 220 has a biased expanded configuration and can be manipulated and/or deformed (e.g., compressed and/or constrained) and, when released, return to its original unconstrained shape.
- outer frame 220 can be formed of materials, such as metals or plastics, that have shape memory properties.
- metals Nitinol ® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic.
- Other shape memory alloys such as Cu-Zn-Al-Ni alloys, and Cu-Al-Ni alloys, may also be used.
- outer frame assembly 210 has an upper end (e.g., at the atrium portion 216), a lower end (e.g., at. the ventricle portion 212), and a medial portion (e.g., at the annulus portion 214) therebetween.
- the upper end or atrium portion 216 (also referred to as "free end portion” or "open end portion") defines an open end portion of the outer frame assembly 210.
- the medial or annulus portion 214 of the outer frame assembly 210 has a perimeter that is configured (e.g., sized, shaped) to fit into an annulus of a native atrioventricular valve.
- the upper end of the outer frame assembly 210 has a perimeter that is larger than the perimeter of the medial portion.
- the perimeter of the upper end of the outer frame assembly 210 has a perimeter that is substantially larger than the perimeter of the medial portion. As shown best in FIG. 5 , the upper end and the medial portion of the outer frame assembly 210 has a D-shaped cross-section. In this manner, the outer frame assembly 210 promotes a suitable fit into the annulus of the native atrioventricular valve.
- Inner valve assembly 240 includes an inner frame 250, an outer covering 260, and leaflets 270. As shown, the inner valve assembly 240 includes an upper portion having a periphery formed with multiple arches.
- the inner frame 250 includes six axial posts or frame members that support outer covering 260 and leaflets 270.
- Leaflets 270 are attached along three of the posts, shown as commissure posts 252 (best illustrated in FIG. 4 ), and outer covering 260 is attached to the other three posts, 254 (best illustrated in FIG. 4 ), and optionally to commissure posts 252.
- Each of outer covering 260 and leaflets 270 can be formed as described above for outer covering 160 and leaflets 170.
- each of outer covering 260 and leaflets 270 can be formed of approximately rectangular sheets of material, which are joined together at their upper, or atrium end.
- the lower, ventricle end of outer covering 260 may be joined to inner covering 232 of outer frame assembly 210, and the lower, ventricle end of leaflets 270 may form free edges 275, though coupled to the lower ends of commissure posts 252.
- inner valve assembly 240 is shown as having three leaflets, in other embodiments, an inner valve assembly can include any suitable number of leaflets.
- the leaflets 270 are movable between an open configuration and a closed configuration in which the leaflets 270 coapt, or meet in a sealing abutment.
- Outer covering 230 of the outer frame assembly 210 and inner covering 232 of outer frame assembly 210, outer covering 260 of the inner valve assembly 240 and leaflets 270 of the inner valve assembly 240 may be formed of any suitable material, or combination of materials, such as those discussed above for valve 100.
- the inner covering 232 of the outer frame assembly 210, the outer covering 260 of the inner valve assembly 240, and the leaflets 270 of the inner valve assembly 240 are formed, at least in part, of porcine pericardium.
- the outer covering 230 of the outer frame assembly 210 is formed, at least in part, of polyester.
- Prosthetic valve 200 also defines a tapered annular space or pocket (not shown) formed between the outer surface of inner valve assembly 240 and the inner surface of outer frame assembly 210, open to the atrium end of valve assembly 200.
- a pocket closure or covering 280 (the pocket being disposed below pocket closure 280 in the top view of FIG. 5 ) is coupled along the periphery of the upper end of the inner valve assembly 240 and also to the outer valve assembly 210.
- the pocket closure 280, or a portion thereof can be coupled along any suitable portion of the inner valve assembly 240.
- pocket closure 280 can be formed at least in part of any suitable material that is sufficiently porous to allow blood, including particularly red blood cells, to enter the pocket, but is not so porous as to allow undesirably large thrombi to leave the pocket.
- pocket closure 280 is formed entirely of knit polyester (i.e., PET warp knit fabric) having apertures of about 90-120 microns.
- a pocket closure can include apertures less than about 160 microns.
- a prosthetic heart valve such as a prosthetic mitral valve
- the outer frame can be moved or inverted relative to the inner frame of the valve.
- the prosthetic valve can be inserted into a lumen of a delivery sheath such that the prosthetic valve is moved to a collapsed configuration for delivery of the valve o the heart.
- FIGS. 6A-6D and FIGS.7A and 7B illustrate schematically an embodiment of a prosthetic valve that can be moved between a biased expanded configuration for use and an inverted configuration for delivery to a heart.
- FIGS. 6A and 6B are schematic illustrations of a portion of a prosthetic heart valve 300, according to an embodiment, shown in a first configuration and a second configuration respectively, and FIGS. 6C and 6D illustrate the portions of the prosthetic heart valve 300 of FIGS. 6A and 6B , respectively, shown disposed within a lumen of a delivery sheath 326.
- FIGS. 7A and 7B illustrate a portion of the prosthetic heart valve 300 of FIGS. 6A and 6B , respectively, and show length dimensions for the prosthetic heart valve in each of the first configuration and the second configuration.
- the prosthetic heart valve 300 (also referred to herein as "prosthetic valve” or "valve”) can be, for example, a prosthetic mitral valve.
- the valve 300 includes an outer frame 320 and an inner frame 350.
- the outer frame 320 and the inner frame 350 are each formed as a tubular structure.
- the outer frame 320 and the inner frame 350 can be coupled together at multiple coupling joints 346 disposed about a perimeter of the inner frame 350 and a perimeter of the outer frame 320 as described in more detail below.
- the valve 300 can also include other features, such as those described above with respect to FIGS. 1-5 .
- the valve 300 can include an outer frame assembly, including the outer frame 320, and an inner valve assembly that includes the inner frame 350, that can be formed or configured the same as or similar to the outer frame assemblies and inner valve assemblies described above with respect to FIGS. 1-5 .
- FIGS. 6A-7B For illustration purposes, only the inner frame 350 and the outer frame 320 are discussed with respect to FIGS. 6A-7B .
- the various characteristics and features of valve 300 described with respect to FIGS. 6A-7B can apply to any of the prosthetic valves described here.
- the outer frame 320 is configured to have a biased expanded or undeformed shape and can be manipulated and/or deformed (e.g., compressed or constrained) and, when released, return to its original (expanded or undeformed) shape.
- the outer frame 320 can be formed of materials, such as metals or plastics, that have shape memory properties.
- metals Nitinol ® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic.
- Other shape memory alloys such as Cu-Zn-Al-Ni alloys, and Cu-Al-Ni alloys, may also be used.
- the inner frame 350 can be formed from a laser-cut tube of Nitinol ® .
- the inner frame 350 can also have a biased expanded or undeformed shape and can be manipulated and/or deformed (e.g., compressed and/or constrained) and, when released, return to its original (expanded or undeformed) shape. Further details regarding the inner frame 350 and the outer frame 320 are described below and with respect to valve 200 and FIGS. 3-5 .
- the valve 300 can be delivered and deployed within a left atrium of a heart using a variety of different delivery approaches including, for example, a transfemoral delivery approach, as described in the '572 PCT application, or a transatrial approach, as described in the '704 provisional application and the '221 application, or a transjugular approach as described, for example, in the '221 application.
- a transfemoral delivery approach as described in the '572 PCT application
- a transatrial approach as described in the '704 provisional application and the '221 application
- a transjugular approach as described, for example, in the '221 application.
- the size of the prosthetic valve during delivery should be sized accordingly.
- a prosthetic valve that can be reconfigured between a biased expanded configuration for implantation in the heart (e.g., within a native mitral annulus) and a delivery configuration that has a smaller outer perimeter or profile to allow for delivery within the lumen of the delivery sheath.
- the prosthetic valve 300 and the embodiments of a prosthetic valve described herein can be constructed and formed to achieve these desired functions and characteristics.
- the valve 300 can have a biased expanded configuration (as shown in FIGS. 6A and 7A ), an inverted configuration (as shown in FIGS. 6B and 7B ), and a compressed or collapsed configuration (as shown in FIGS. 6C and 6D ).
- the expanded configuration allows the valve 300 to function when implanted within the heart.
- the valve 300 can be moved to the inverted configuration and the compressed or collapsed configuration for delivery of the valve 300 to the heart of a patient.
- the outer frame 320 can be coupled to the inner frame 350 in such a manner to allow the outer frame 320 to move relative to the inner frame 350.
- the coupling joints 346 can couple the outer frame 320 to the inner frame 350 in such a manner to allow the outer frame 320 to be moved relative to the inner frame 350.
- the coupling joints 346 can be configured to allow the outer frame 320 to rotate about the coupling joint 346 relative to the inner frame 350.
- coupling joints can provide a pivotal coupling between the outer frame 320 and the inner frame 350.
- the coupling joints can provide a flexible attachment between the outer frame 320 and the inner frame 350.
- the coupling joints 346 can be a variety of different types and configurations as described herein with reference to the various embodiments of a prosthetic valve.
- the coupling joints 146 can include a living hinge, a flexible member, sutures, a suture wrapped through an opening, a pin or tab inserted through an opening or any combinations thereof.
- the outer frame 320 is moved to a prolapsed or inverted configuration relative to the inner frame 350, as shown in FIGS. 6B , 6D and 7B , by moving (e.g., rotating, pivoting, flexing) the outer frame 320 about the coupling joints 346.
- the elastic or superelastic structure of outer frame 320 of valve 300 also allows the outer frame 320 to be moved to, and disposed in, the prolapsed or inverted configuration relative to the inner frame 350.
- the outer frame 320 is folded or inverted distally (to the right in FIG.
- the outer frame 320 is in a first position relative to the inner frame 350 prior to being inverted in which an open or free end portion 316 (also referred to the atrium portion 316 of the outer frame 320) is disposed proximally or to the left of the coupling joints 346 and in the same direction as a free end portion 347 (also referred to as a second end portion of the inner frame) of the inner frame 350.
- an open or free end portion 316 also referred to the atrium portion 316 of the outer frame 320
- a free end portion 347 also referred to as a second end portion of the inner frame
- the free end portion 316 is disposed distally of the coupling joints 346 (or to the right in FIGS. 6B and 7B ) and in an opposite direction as the free end portion 347 of the inner frame 350.
- the coupling joints 346 are disposed between a first end portion 344 (also referred to as a tether coupling portion) of the inner frame 350 and the free end portion 316 of the outer frame 320.
- the coupling joints 346 are disposed between the free end portion or second end portion 347 of the inner frame 350 and the free end portion 316 of the outer frame 320.
- an overall length of the valve 300 is increased, but a length of the inner frame 350 and a length of the outer frame 320 remains the same (or substantially the same).
- an overall length L1 of the valve 300 in the biased expanded configuration is less than the overall length L2 of the valve 300 when in the inverted configuration ( FIG. 7B ).
- a length Li of the inner frame 350 and a length L O of the outer frame 320 is substantially the same (or the same) when the valve 300 is in both the biased expanded configuration and the inverted configuration.
- an overall outer perimeter or outer diameter of the valve 300 can be smaller when the valve 300 is in the inverted configuration.
- valve 300 With the valve 300 in the inverted configuration, the valve 300 can be placed within a lumen of the delivery sheath 326 for delivery of the valve 300 to the left atrium of the heart, as shown in FIG. 6D .
- the valve 300 When placed within the lumen of the delivery sheath 326, the valve 300 is moved to the collapsed or compressed configuration in which the outer diameter or outer perimeter of the valve 300 is reduced. Because the valve 300 is in the inverted configuration, the valve 300 is able to be placed within a smaller delivery sheath 326 than would otherwise be possible.
- FIG. 6C illustrates the valve 300 placed within a lumen of a delivery sheath 326' where the valve 300 has not been moved to an inverted configuration prior to being disposed within the delivery sheath 326'.
- an outer diameter of the valve 300 is reduced, but not to as small of a diameter as for the valve 100 when placed in a delivery sheath 326 when in the inverted configuration.
- the valve 300 has an overall outer perimeter or outer diameter D1 and in FIG. 6D , the valve 300 has an overall outer perimeter or outer diameter D2, which is less than D1.
- the valve 300 can be collapsed into a smaller overall diameter, i.e. placed in a smaller diameter delivery sheath 326, than would be possible if the valve 300 were merely collapsed radially.
- the inner frame 350 is nested within an interior of the outer frame 320, and thus the outer frame 320 must be collapsed around the inner frame 350.
- the inner frame 350 and the outer frame are disposed concentrically.
- the inner frame 350 and the outer frame 320 are arranged axially with respect to each other (i.e., the inner frame is not nested within the outer frame 350), such that the outer frame 320 can be collapsed without needing to accommodate all of the structure of the inner frame 350 inside it.
- the inner frame 350 disposed mostly inside or nested within the outer frame 320, the layers or bulk of the frame structures cannot be compressed to as small a diameter.
- the structure is less flexible, and therefore, more force is needed to bend the valve, e.g. to pass through tortuous vasculature or to make tight turn in the left atrium after passing through the atrial septum to be properly oriented for insertion into the mitral valve annulus.
- FIGS. 8A and 8B illustrate another embodiment of a prosthetic heart valve that can be delivered and deployed within a left atrium of a heart using a variety of different delivery approaches and which can be moved between an expanded configuration and an inverted configuration as described above for valve 300.
- the prosthetic heart valve 400 (also referred to herein as "prosthetic valve” or “valve”) can be, for example, a prosthetic mitral valve.
- the valve 400 includes an outer frame assembly including an outer frame 420 and an inner valve assembly including an inner frame 450.
- the outer frame 420 and the inner frame 450 are each formed as a tubular structure.
- the valve 400 can also include other features, such as those described above with respect to FIGS. 1A -7D. For illustration purposes, only the inner frame 450 and the outer frame 420 are discussed with respect to FIGS. 8A-8B . It should be understood that the various characteristics and features of the valves described above with respect to FIGS. 1A -7D can apply to valve 400.
- the outer frame 420 and the inner frame 450 can be coupled together at multiple coupling joints 446 disposed about a perimeter of the inner frame 450 and a perimeter of the outer frame 420 as described above for valve 300.
- the coupling joints 446 can allow the outer frame 420 to be moved relative to the inner frame 450 as described above for valve 300.
- the outer frame 420 can be moved between a first position ( FIG. 8A ) relative to the inner frame 450 to a second position ( FIG. 8B ) relative to the inner frame 450.
- a first position FIG. 8A
- FIG. 8B a second position relative to the inner frame 450.
- an open free end portion 416 of the outer frame 420 is disposed in the same direction as an open free end portion 447 of the inner frame 450 (see FIG. 8A ).
- the outer frame 420 is inverted relative to the inner frame 450 such that the free end portion 416 of the outer frame 420 is now disposed in an opposite direction as the free end portion 447 of the inner frame
- a tapered annular space or pocket 485 (also referred to as "atrial pocket”) is formed between an outer surface of the inner valve assembly and an inner surface of the outer frame assembly, open to an atrium end of valve 400.
- atrium pocket When valve 400 is disposed in the annulus of a native heart valve, blood from the atrium can move in and out of pocket 485. The blood can clot, forming thrombus.
- the pocket 485 is covered, or enclosed, by a pocket closure 480 (also referred to as an "atrial pocket closure").
- the pocket closure 480 is coupled about a perimeter of the inner frame 450 and a perimeter of the outer frame 420 so as to close-out the pocket 485 at the atrial end of the valve 400. As shown in FIGS. 8A and 8B the pocket closure 480 is coupled to the inner frame 450 at coupling portion 482 and to outer frame 420 at coupling portion 483.
- the pocket closure 480 can be formed of one continuous segment or portion of material or can be formed with two or more portions or segments that are coupled together. For example, in some embodiments, the pocket closure 480 can be formed of three portions or segments that are sewn together with sutures or another suitable coupling method.
- pocket closure 480 can be formed at least in part of any suitable material that is sufficiently porous to allow blood, including particularly red blood cells, to enter the pocket 485, but is not so porous as to allow undesirably large thrombi to leave the pocket 485.
- pocket closure 480 may be formed at least in part from a material with apertures less than 160 ⁇ , and preferably between 90 ⁇ and 120 ⁇ .
- the pocket closure 480 can be formed at least in part from a braided Nitinol material (or a braided tubular Nitinol material) that has the desired porosity.
- the braided Nitinol material also provides a desired stretchability, flexibility or deformability to accommodate movement of the outer frame 420 between the first positon relative to the inner frame 450 and the second inverted position relative to the inner frame 450.
- the braided Nitinol material can have shape memory properties that allow the pocket closure 480 to be deformed and/or stretched and then revert back to an original shape or configuration when released.
- the pocket closure 480 when the outer frame 420 is in the first position relative to the inner frame 450, the pocket closure 480 is disposed in a first configuration.
- FIG. 8B when the outer frame 420 is in the second position (i.e., inverted) relative to the inner frame 450, the pocket closure 480 is disposed in a second configuration. More specifically, when the outer frame 420 is moved to the second position in which the outer frame 420 is inverted relative to the inner frame 420, the material and structure of the pocket closure 480 enables the pocket closure 480 to stretch with the outer frame 420 as shown in FIG. 8B . In other words, as shown in FIG.
- the pocket closure 480 is stretched or elongated between where it is coupled to the inner frame (i.e., coupling portion 482) and where it is coupled to the outer frame (i.e., coupling portion 483) to a length greater than when the outer frame 420 is in the first positon as shown in FIG. 8A .
- the pocket closure 480 can assume its first configuration as shown in FIG. 8A .
- FIGS. 9A and 9B illustrate another embodiment of a prosthetic heart valve that includes a pocket closure that can accommodate the valve being moved between an expanded configuration and an inverted configuration for delivery and deployment of the valve within a left atrium of a heart.
- the prosthetic heart valve 500 (also referred to herein as "prosthetic valve” or “valve”) can be, for example, a prosthetic mitral valve.
- the valve 500 includes an outer valve assembly including an outer frame 520 and an inner valve assembly including an inner frame 550.
- the outer frame 520 and the inner frame 550 are each formed as a tubular structure.
- the valve 500 can also include other features, such as those described above with respect to FIGS. 1A -7D. For illustration purposes, only the inner frame 550 and the outer frame 520 are discussed with respect to FIGS. 8A-8B . It should be understood that the various characteristics and features of the valves described above with respect to FIGS. 1A-7D can apply to valve 500.
- the outer frame 520 and the inner frame 550 can be coupled together at multiple coupling joints 546 disposed about a perimeter of the inner frame 550 and a perimeter of the outer frame 520 as described above for valve 300.
- the coupling joints 546 can allow the outer frame 520 to be moved relative to the inner frame 550 as described above for valve 300.
- the outer frame 520 can be moved between a first position ( FIG. 9A ) relative to the inner frame 550 to a second position ( FIG. 9B ) relative to the inner frame 550.
- a first position FIG. 9A
- FIG. 9B a second position relative to the inner frame 550.
- an open free end portion 516 of the outer frame 520 is disposed in the same direction as an open free end portion 547 of the inner frame 550 (see FIG. 9A ).
- the outer frame 520 is inverted relative to the inner frame 550 such that the free end portion 516 of the outer frame 520 is now disposed in an opposite direction as the free end portion 547 of the inner frame
- a tapered annular space or pocket 585 (also referred to as "atrial pocket”) is formed between an outer surface of the inner valve assembly and an inner surface of the outer frame assembly, open to an atrium end of valve 500.
- atrium pocket When valve 500 is disposed in the annulus of a native heart valve, blood from the atrium can move in and out of pocket 585. The blood can clot, forming thrombus.
- the pocket 585 is covered, or enclosed, by a pocket closure 580 (also referred to as an "atrial pocket closure").
- the pocket closure 580 includes a first portion 584 coupled to a second portion 586.
- the first portion 584 includes a first end coupled to the outer frame 520 at a coupling joint 587, and a second end coupled to the second portion 586 at a coupling joint 588.
- the second portion 586 has a first end coupled to the first portion 584 at the coupling joint 588 and a second end coupled to the outer frame 520 at a coupling joint 589.
- the pocket closure 580 is coupled only to the outer frame 520.
- the pocket closure 580 can close-out the pocket at the atrial end of the valve 500.
- the first portion 584 and the second portion 586 of the pocket closure 580 can each be formed as one continuous segment or portion of material or can be formed with two or more portions or segments that are coupled together with for example, sutures or another suitable coupling method.
- pocket closure 580 can be formed at least in pail of any suitable material that is sufficiently porous to allow blood, including particularly red blood cells, to enter the pocket 585, but is not so porous as to allow undesirably large thrombi to leave the pocket 585.
- pocket closure 580 may be formed at least in part from a material with apertures less than 160 ⁇ , and preferably between 90 ⁇ and 120 ⁇ .
- the first portion 584 of pocket closure 580 can be formed at least in part from a woven or knit polyester fabric with apertures less than 160 ⁇ , and preferably between 90 ⁇ and 120 ⁇ .
- the second portion 586 of pocket closure 580 can be formed with a tubular braided Nitinol material as described above for valve 400 that can provide a desired stretchability or flexibility or deformability to accommodate the outer frame 520 moving between the first positon relative to the inner frame 550 and the second inverted position relative to the inner frame 550.
- the pocket closure 580 when the outer frame 520 is in the first position relative to the inner frame 550, the pocket closure 580 is disposed in a first configuration.
- FIG. 9B when the outer frame 520 is in the second position (i.e., inverted) relative to the inner frame 550, the pocket closure 580 is disposed in a second configuration. More specifically, when the outer frame 520 is moved to the second position in which the outer frame 520 is inverted relative to the inner frame 520, the material and structure of the second portion 586 of the pocket closure 580 enables the pocket closure 580 to stretch with the outer frame 520 as shown in FIG. 9B . In other words, as shown in FIG.
- the second portion 586 of pocket closure 580 can stretch or elongate between where it is coupled to the first portion 584 of the pocket closure 580 (i.e., coupling joint 588) and where it is coupled to the outer frame 520 (i.e., coupling portion 589) to a length greater than when the outer frame 520 is in the first positon as shown in FIG. 9A .
- the first portion 584 of pocket closure 580 does not stretch when the outer frame 520 is moved to the second position (i.e., inverted) relative to the inner frame 550.
- the pocket closure 580 can assume its first configuration as shown in FIG. 9A .
- an additional material layer can be attached to the inner frame in addition to the outer covering described above for previous embodiments (e.g., outer covering 160).
- the additional material layer can be attached to an inner face or an outer face of the inner frame of the valve.
- the additional material layer can be attached to an inner face of the inner frame and outside of the leaflets of the valve.
- the outer covering can be disposed between the leaflets and the additional material layer, with all three components (leaflets, outer covering and additional material layer) disposed on an inner side of the inner frame of the valve.
- the additional material layer may be desirable to prevent possible billowing of the belly area of the leaflet.
- FIGS. 10A-10C illustrate a prosthetic heart valve 600 that includes such a material layer 625.
- the material layer 625 is disposed as a cylinder that covers an inner frame 650 from a base 622 of the inner frame 650 to a peak or atrium end 624 of the inner frame 650.
- the valve 600 includes leaflets 670. As shown in FIG. 10A and 10B , the valve 600 includes leaflets 670.
- the cylindrically disposed material layer 625 bridges the peaks 624 of the frame 650.
- the material layer can be configured to follow the shape of the inner frame as shown in FIG. 10D .
- a valve 600' includes a material layer 625' that substantially follows or conforms to the shape of the inner frame 650. In other words, the material layer 625' spans between frame portions of the inner frame 650.
- the material layers 625, 625' can be, for example, a polyester material.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Description
- Prosthetic heart valves, including those for insertion into atrioventricular valves (tricuspid and mitral valves) are susceptible to various problems, including problems with insufficient articulation and sealing of the valve within the native valve annulus, pulmonary edema due to poor atrial drainage, perivalvular leaking around the install prosthetic valve, lack of a good fit for the prosthetic valve within the native valve annulus, atrial tissue erosion, excess wear on the Nitinol structures, interference with the aorta at the anterior side of the mitral annulus, lack of customization, and thrombus formation, to name a few. Accordingly, there is a need for a prosthetic heart valve that can address some or all of these problems.
- Moreover, there are a variety of different delivery approaches for delivering and deploying a prosthetic heart valve into atrioventricular valves and depending on the delivery approach the desired features and structure of a prosthetic heart valve can vary. For example, in transvascular delivery of a prosthetic heart valve it is desirable to have a prosthetic heart valve that can have an expanded configuration for implantation within the heart and a collapsed or compressed configuration that has a sufficiently small outer perimeter or diameter to allow the prosthetic heart valve to be placed in a relatively small delivery catheter or sheath. In such embodiments of a prosthetic heart valve, it is also desirable for features of the prosthetic heart valve, such as those described above, to be maintained.
-
WO 2014/210124 A1 describes a prosthetic heart valve which may include an outer support assembly, an inner valve assembly, which define between them an annular space, and a pocket closure that bounds the annular space to form a pocket in which thrombus can be formed and retained. -
US 2015/0327995 A1 describes a prosthetic heart valve including a collapsible and expandable stent extending from an inflow end to an outflow end and a plurality of prosthetic valve leaflets coupled to the stent. The prosthetic heart valve may also include a sealing ring coupled to the inflow end of the stent, the sealing ring comprising a tube extending circumferentially around the inflow end of the stent. -
WO 2015/120122 A2 describes apparatus and methods for use in the transfemoral delivery and deployment of a prosthetic mitral valve, wherein a method may include inverting an outer frame of a prosthetic mitral valve when in a biased expanded configuration. -
WO 2014/144937 A2 describes prosthetic heart valve devices for pay cutaneous replacement of native heart valves and associated systems and methods, wherein a prosthetic heart valve device may include an anchoring member having an upstream portion configured to engage with tissue on or near the annulus of the native heart valve and to deform in a non-circular shape to conform to the tissue. The device can also include a mechanically isolated valve support coupled to the anchoring member and configured to support a prosthetic valve. - The invention relates to a prosthetic heart valve and is defined in the appended claims. According to the invention, the prosthetic heart valve includes an outer frame coupled to an inner frame such that the outer frame can be moved between a first position relative to the inner frame and a second position relative to the inner frame in which the outer frame is inverted relative to the inner frame. The inner frame and the outer frame define between them an annular space. In some embodiments, a pocket closure bounds the annular space to form a pocket in which thrombus can form and be retained. The pocket closure can include a stretchable pocket covering that can move from a first position in which the pocket covering has a first length when the outer frame is in the first position relative to the inner frame and a second position in which the pocket covering has a second length greater than the first length when the outer frame is in the second position relative to the inner frame.
-
-
FIGS. 1A and 1B are a schematic perspective view and a side cross-sectional view, respectively, of a prosthetic heart valve, according to an embodiment. -
FIGS. 2A is a schematic perspective view, of an inner valve assembly of the prosthetic heart valve ofFIGS. 1A and 1B . -
FIGS. 2B and 2C are schematic top views of the inner valve ofFIG. 2A , shown in a first configuration and a second configuration, respectively. -
FIGS. 3-5 are front, bottom, and top views, respectively, of a prosthetic heart valve . -
FIGS. 6A and 6B are schematic illustrations of a portion of a prosthetic heart valve, shown in a first configuration and a second configuration, respectively. -
FIGS. 6C and 6D are schematic illustrations of the portion of the prosthetic heart valve ofFIGS. 6A and 6B , respectively, shown disposed within a delivery sheath. -
FIGS. 7A and 7B are schematic illustrations of the portion of a prosthetic heart valve ofFIGS. 6A and 6B , shown in the first configuration and the second configuration, respectively. -
FIG. 8A is a front view of a prosthetic heart valve according to an embodiment of the invention shown in a first configuration. -
FIG. 8B is a front view of the prosthetic heart valve ofFIG. 8A , shown in a second configuration. -
FIG. 9A is a front view of a prosthetic heart valve according to another embodiment of the invention, shown in a first configuration. -
FIG. 9B is an enlarged view of encircled portion A of the prosthetic heart valve ofFIG. 9A . -
FIG. 9C is a front view of the prosthetic heart valve ofFIG. 9A , shown in a second configuration. -
FIG. 10A is a cross-sectional side view of a prosthetic heart valve, according to another embodiment of the invention. -
FIG. 10B is an enlarged view of encircled area A inFIG. 10A . -
FIG. 10C is a perspective view of the prosthetic heart valve ofFIG. 10A . -
FIG. 10D is a perspective view of a prosthetic heart valve, according to another embodiment of the invention. . - Prosthetic heart valves are described herein that include an outer frame coupled to an inner frame. The outer frame and the inner frame define between them an annular space, and a pocket closure bounds the annular space to form a pocket in which thrombus can form and be retained. According to the invention, a prosthetic heart valve includes an outer frame coupled to an inner frame such that the outer frame can be moved between a first position relative to the inner frame and a second position relative to the inner frame in which the outer frame is inverted relative to the inner frame. In an embodiment according to the invention, the pocket closure can include a stretchable pocket covering that can move from a first position in which the pocket covering has a first length when the outer frame is in the first position relative to the inner frame and a second position in which the pocket covering has a second length greater than the first length when the outer frame is in the second position relative to the inner frame.
- In some embodiments, prosthetic heart valves described herein can be configured to be moved to an inverted configuration for delivery of the prosthetic valve to within a heart of a patient. According to the invention, a prosthetic valve includes an outer frame that can be inverted relative to an inner frame when the prosthetic valve is in a biased expanded configuration. The prosthetic mitral valve can be formed with, for example, a shape-memory material. After inverting the outer frame, the prosthetic valve can be inserted into a lumen of a delivery sheath such that the prosthetic valve is moved to a collapsed configuration.
- The delivery sheath can be used to deliver an inverted prosthetic valve as described herein to within a patient's heart using a variety of different delivery approaches for delivering a prosthetic heart valve (e.g., prosthetic mitral valve) where the inverted prosthetic valve would enter the heart through the atrium of the heart. For example, the prosthetic valves described herein can be delivered using a transfemoral delivery approach as described in International Application No.
PCT/US15/14572 (the '572 PCT application) published asWO2015120122 A2 , above or via a transatrial approach, such as described inU.S. Provisional Patent Application Serial No. 62/220,704, entitled "Apparatus and Methods for Transatrial Delivery of Prosthetic Mitral Valve," filed September 18, 2015 U.S. Patent Application No. 15/265,221 filed September 14, 2016 US2017079790 A1 . - In another example, an inverted valve as described herein could be delivered via a transjugular approach, via the right atrium and through the atrial septum and into the left atrium, as described in the '221 application. The prosthetic valves described herein can also be delivered apically if desired. After the delivery sheath has been disposed within the left atrium of the heart, the prosthetic mitral valve is moved distally out of the delivery sheath such that the inverted outer frame reverts and the prosthetic valve assumes its biased expanded configuration. The prosthetic mitral valve can then be positioned within a mitral annulus of the heart.
- A schematic representation of a
prosthetic heart valve 100 is shown inFIGS. 1A and 1B . Prosthetic heart valve 100 (also referred to as "prosthetic valve" or "valve") is designed to replace a damaged or diseased native heart valve such as a mitral valve.Valve 100 includes an outer frame assembly 110 and aninner valve assembly 140 that is coupled to the outer frame assembly. - Although not separately shown in the schematic illustration of outer frame assembly 110 in
FIGS. 1A and 1B , outer fame assembly 110 may be formed of an outer frame 120, and can be covered on all or a portion of its outer face with an outer covering (not shown), and covered on all or a portion of its inner face by an inner covering (not shown). An embodiment of a prosthetic valve showing the inner and outer coverings is described below with respect toFIGS. 3-5 . In some embodiments, the outer frame assembly 110 can include a covering on only an outer face or only an inner face of the outer frame 120. In some embodiments, there can be more than one layer of covering on the inner face and/or the outer face of the outer frame 120. The inner and outer coverings of the outer frame assembly 110 can completely cover the inner face and/or outer face of the outer frame 120 or can partially cover the inner face and/or the outer face of the outer frame 120. In some embodiments, the outer frame assembly 110 may not include a covering on the inner face or the outer face of the outer frame 120. For example, in some embodiments, the outer frame assembly 110 can include no material or covering on an inner face of the outer frame 120 and two layers or coverings disposed on an outer face of the outer frame 120. In such an embodiment, a first layer or covering can be, for example, a tissue that fully covers the outer face of the outer frame 120 and the outermost layer or covering can be a thin polyester that covers only a portion of the outer frame 120. For example, the outermost covering can cover one or two rows of cells of a cuff portion of the outer frame 120. - Outer frame 120 can provide several functions for
prosthetic heart valve 100, including serving as the primary structure, as an anchoring mechanism and/or an attachment point for a separate anchoring mechanism to anchor the valve to the native heart valve apparatus, a support to carryinner valve assembly 140, and/or a seal to inhibit paravalvular leakage betweenprosthetic heart valve 100 and the native heart valve apparatus. - Outer frame 120 is preferably formed so that it can be deformed (compressed and/or expanded) and, when released, return to its original (undeformed) shape. To achieve this, outer frame 120 is preferably formed of materials, such as metals or plastics, that have shape memory properties. With regards to metals, Nitinol® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic. Other shape memory alloys, such as Cu-Zn-Al-Ni alloys, and Cu-Al-Ni alloys, may be used.
- Outer frame 120 is preferably formed from a laser cut, thin-walled tube of Nitinol®. The laser cuts form regular cutouts in the thin Nitinol® tube. The tube can be expanded radially, placed on a mold or mandrel of the desired shape, heated to the martensitic temperature, and quenched. The treatment of the frame in this manner will form an open lattice frame structure, and may have a flared end or cuff at the
atrium end portion 116 of outer frame 120. Outer frame 120 thus has shape memory properties and will readily revert to the memory shape at the calibrated temperature. Alternatively, outer frame 120 may be constructed from braided wire or other suitable material. -
Inner valve assembly 140 is shown schematically in more detail inFIGS. 2A-2C .Inner valve assembly 140 can include aninner frame 150, anouter covering 160, andleaflets 170. In the simplified form shown schematically inFIG. 2A ,inner frame 150 includes six axial posts or frame members that supportouter covering 160 andleaflets 170.Leaflets 170 are attached along three of the posts, shown as commissure posts 152 inFIG. 2A , andouter covering 160 is attached to the other three posts, 154 inFIG. 2A , and optionally to commissure posts 152. Theouter covering 160 can be attached to an inner face of theinner frame 150 or to an outer face of theinner frame 150. As shown schematically inFIG. 2A , each ofouter covering 160 andleaflets 170 are formed of approximately rectangular sheets of material, which are joined together at their upper, or atrium end. The lower, ventricle end ofouter covering 160 may be joined to the inner covering (not shown) of outer frame assembly 110 (not shown inFIG. 2A ), and the lower, ventricle end ofleaflets 170 may form free edges, though coupled to the lower ends of commissure posts 152. In some embodiments, the covering 160 andleaflets 170 can be formed from a single rectangular sheet of material, then folded over and trimmed to the shape of the inner frame, staying connected at the top of the inner frame where the material is folded over. In some embodiments, the covering 160 and/or theleaflets 170 can be formed from material having a shape other than rectangular, such as from a semi-circular piece of material, or can be laser cut to the shape of the inner frame. - As shown in
FIGS. 2B and 2C ,leaflets 170 are movable between a first or open configuration (FIG. 2B ), and a second or closed configuration (FIG. 2C ) in which theleaflets 170 coapt, or meet in sealing abutment. - At the lower, or ventricle end,
leaflets 170 may have a smaller outer perimeter thanouter covering 160. Thus, the free lower edges of theleaflets 170, between commissure posts 152 (each portion ofleaflets 170 between adjacent commissure posts being referred to as a "belly" of leaflets 170) are spaced radially from the lower edge ofouter covering 160. This radial spacing facilitates movement of the leaflets from the open position inFIG. 2B to the closed position inFIG. 2C , as the counter flow of blood from the ventricle to the atrium during systole can catch the free edges of the bellies and push the leaflets closed. - The outer covering and the inner covering of outer frame assembly 110,
outer covering 160 andleaflets 170 may be formed of any suitable material, or combination of materials. In some embodiments, the outer covering and the inner covering of outer frame assembly 110,outer covering 160 andleaflets 170 may be formed of a tissue. In some embodiments, the tissue is optionally a biological tissue, such as a chemically stabilized tissue from a heart valve of an animal, such as a pig, or pericardial tissue of an animal, such as cow (bovine pericardium) or sheep (ovine pericardium) or pig (porcine pericardium) or horse (equine pericardium). Examples of suitable tissue include that used in the products Duraguard®, Peri-Guard®, and Vascu-Guard®, all products currently used in surgical procedures, and which are marketed as being harvested generally from cattle less than 30 months old. Alternatively,valve leaflets 170 may optionally be made from pericardial tissue or small intestine submucosal tissue. - Synthetic materials, such as polyurethane or polytetrafluoroethylene, may also be used for
valve leaflets 170. Where a thin, durable synthetic material is contemplated, e.g. for the outer covering or the inner covering of outer frame assembly 110, synthetic polymer materials such as, for example, expanded polytetrafluoroethylene or polyester may optionally be used. Other suitable materials may optionally include thermoplastic polycarbonate urethane, polyether urethane, segmented polyether urethane, silicone polyether urethane, silicone-polycarbonate urethane, and ultra-high molecular weight polyethylene. Additional biocompatible polymers may optionally include polyolefins, elastomers, polyethyleneglycols, polyethersulphones, polysulphones, polyvinylpyrrolidones, polyvinylchlorides, other fluoropolymers, silicone polyesters, siloxane polymers and/or oligomers, and/or polylactones, and block co-polymers using the same. - In another embodiment,
valve leaflets 170 may optionally have a surface that has been treated with (or reacted with) an anti-coagulant, such as, without limitation, immobilized heparin. Such currently available heparinized polymers are known and available to a person of ordinary skill in the art. - As shown in
FIGS. 1A, 1B , and2A ,inner valve assembly 140 may be substantially cylindrical, and outer frame assembly 110 may be tapered, extending from a smaller diameter (slightly larger than the outer diameter of inner valve assembly 140) at a lower, ventricle portion 112 (where it is coupled to inner valve assembly 140) to a larger diameter,atrium portion 116, with an intermediate diameter,annulus portion 114 between the atrium and ventricle portions, 112 and 116, respectively. - A tapered annular space or pocket 185 (also referred to herein as "atrial pocket") is thus formed between the outer surface of
inner valve assembly 140 and the inner surface of outer frame assembly 110, open to the atrium end ofvalve assembly 100. Whenvalve assembly 100 is disposed in the annulus of a native heart valve, blood from the atrium can move in and out ofpocket 185. The blood can clot, forming thrombus. To enhance clotting, ingrowth of tissue into the surfaces ofvalve 100, and produce other benefits, the pocket can be covered, or enclosed, by a pocket closure 180 (also referred to as an "atrial pocket closure"). -
Pocket closure 180 can be formed at least in part of any suitable material that is sufficiently porous to allow blood, including particularly red blood cells, to enterpocket 185, but is not so porous as to allow undesirably large thrombi to leave thepocket 185. For example,pocket closure 180 may be formed at least in part from a woven or knit polyester fabric with apertures less than 160 µ, and preferably between 90 µ and 120 µ. In some embodiments, thepocket closure 180 can be formed at least in part from a braided Nitinol material that has a desired porosity. In some embodiments, thepocket closure 180 can be formed at least in part from a braided tubular Nitinol material. It is not necessary for the entirety ofpocket closure 180 to be formed of the same material, with the same porosity. For example, some portions ofpocket closure 180 may be formed of a less porous, or blood impermeable, material and other portions formed of material of the porosity range noted above. It is also contemplated that a portion of the outer frame assembly 110 or theinner valve assembly 140 may be formed with an aperture that communicates withpocket 180, covered by a closure formed of material having the desired porosity, thus providing another path by which blood may enter, but thrombi are prevented from leaving,atrial pocket 185. - The outer surface of inner valve assembly 110, and/or the inner surface of
outer frame assembly 140, need not by circular in cross-section as shown schematically inFIGS. 1A and 1B , but may be of non-constant radius at a given location along the central axis ofvalve 100. Thus,pocket 185 may not be of constant cross-section, and may not be continuous, but rather may be formed in two or more fluidically isolated, partially annular volumes. Similarly,pocket closure 180 need not be shaped as a ring with constant width as shown schematically inFIGS. 1A and 1B , but rather can be a continuous ring of varying with, a more complicated continuous shape, or may be formed in multiple, discrete sections. In some embodiments, thepocket closure 180 can be formed as a tubular member defining an interior region. -
Pocket closure 180 serves to trap and/or slow the flow of blood withinpocket 185, which can increase formation and retention of thrombus inpocket 185. It also promotes active in-growth of native tissue into the several coverings ofprosthetic heart valve 100, further stabilizingvalve 100 in the native heart valve. The material forming the outer covering ofinner valve assembly 140 can also be hardened or stiffened, providing better support forleaflets 170. Also, a mass ofthrombus filling pocket 185 can serve as potting forinner valve assembly 140, further stabilizing the valve assembly. Greater stability forinner valve assembly 140 can provide more reliable coaption ofvalve leaflets 170, and thus more effective performance. The mass of thrombus can also stabilize the outer frame assembly 110 after it has been installed in, and flexibly conformed to, the native valve apparatus. This can provide a more effective seal betweenprosthetic heart valve 100 and the native valve apparatus, and reduce perivalvular leakage. -
FIGS. 3-5 are front, bottom, and top views, respectively, of aprosthetic heart valve 200 according to an embodiment. Prosthetic heart valve 200 (also referred to herein as "valve" or "prosthetic valve") is designed to replace a damaged or diseased native heart valve such as a mitral valve.Valve 200 includes anouter frame assembly 210 and aninner valve assembly 240 coupled to theouter frame assembly 210. - As shown,
outer frame assembly 210 includes anouter frame 220, covered on all or a portion of its outer face with anouter covering 230, and covered on all or a portion of its inner face by aninner covering 232.Outer frame 220 can provide several functions forprosthetic heart valve 200, including serving as the primary structure, as an anchoring mechanism and/or an attachment point for a separate anchoring mechanism to anchor the valve to the native heart valve apparatus, a support to carryinner valve assembly 240, and/or a seal to inhibit paravalvular leakage betweenprosthetic heart valve 200 and the native heart valve apparatus. -
Outer frame 220 has a biased expanded configuration and can be manipulated and/or deformed (e.g., compressed and/or constrained) and, when released, return to its original unconstrained shape. To achieve this,outer frame 220 can be formed of materials, such as metals or plastics, that have shape memory properties. With regards to metals, Nitinol® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic. Other shape memory alloys, such as Cu-Zn-Al-Ni alloys, and Cu-Al-Ni alloys, may also be used. - As best shown in
FIG. 3 ,outer frame assembly 210 has an upper end (e.g., at the atrium portion 216), a lower end (e.g., at. the ventricle portion 212), and a medial portion (e.g., at the annulus portion 214) therebetween. The upper end or atrium portion 216 (also referred to as "free end portion" or "open end portion") defines an open end portion of theouter frame assembly 210. The medial orannulus portion 214 of theouter frame assembly 210 has a perimeter that is configured (e.g., sized, shaped) to fit into an annulus of a native atrioventricular valve. The upper end of theouter frame assembly 210 has a perimeter that is larger than the perimeter of the medial portion. In some embodiments, the perimeter of the upper end of theouter frame assembly 210 has a perimeter that is substantially larger than the perimeter of the medial portion. As shown best inFIG. 5 , the upper end and the medial portion of theouter frame assembly 210 has a D-shaped cross-section. In this manner, theouter frame assembly 210 promotes a suitable fit into the annulus of the native atrioventricular valve. -
Inner valve assembly 240 includes an inner frame 250, anouter covering 260, andleaflets 270. As shown, theinner valve assembly 240 includes an upper portion having a periphery formed with multiple arches. The inner frame 250 includes six axial posts or frame members that supportouter covering 260 andleaflets 270.Leaflets 270 are attached along three of the posts, shown as commissure posts 252 (best illustrated inFIG. 4 ), andouter covering 260 is attached to the other three posts, 254 (best illustrated inFIG. 4 ), and optionally to commissure posts 252. Each ofouter covering 260 andleaflets 270 can be formed as described above forouter covering 160 andleaflets 170. For example, each ofouter covering 260 andleaflets 270 can be formed of approximately rectangular sheets of material, which are joined together at their upper, or atrium end. The lower, ventricle end ofouter covering 260 may be joined toinner covering 232 ofouter frame assembly 210, and the lower, ventricle end ofleaflets 270 may formfree edges 275, though coupled to the lower ends of commissure posts 252. - Although
inner valve assembly 240 is shown as having three leaflets, in other embodiments, an inner valve assembly can include any suitable number of leaflets. Theleaflets 270 are movable between an open configuration and a closed configuration in which theleaflets 270 coapt, or meet in a sealing abutment. -
Outer covering 230 of theouter frame assembly 210 andinner covering 232 ofouter frame assembly 210,outer covering 260 of theinner valve assembly 240 andleaflets 270 of theinner valve assembly 240 may be formed of any suitable material, or combination of materials, such as those discussed above forvalve 100. In this embodiment, theinner covering 232 of theouter frame assembly 210, theouter covering 260 of theinner valve assembly 240, and theleaflets 270 of theinner valve assembly 240 are formed, at least in part, of porcine pericardium. Moreover, in this embodiment, theouter covering 230 of theouter frame assembly 210 is formed, at least in part, of polyester. -
Prosthetic valve 200 also defines a tapered annular space or pocket (not shown) formed between the outer surface ofinner valve assembly 240 and the inner surface ofouter frame assembly 210, open to the atrium end ofvalve assembly 200. As shown, a pocket closure or covering 280 (the pocket being disposed belowpocket closure 280 in the top view ofFIG. 5 ) is coupled along the periphery of the upper end of theinner valve assembly 240 and also to theouter valve assembly 210. In some embodiments, thepocket closure 280, or a portion thereof, can be coupled along any suitable portion of theinner valve assembly 240. - As discussed above,
pocket closure 280 can be formed at least in part of any suitable material that is sufficiently porous to allow blood, including particularly red blood cells, to enter the pocket, but is not so porous as to allow undesirably large thrombi to leave the pocket. In this embodiment,pocket closure 280 is formed entirely of knit polyester (i.e., PET warp knit fabric) having apertures of about 90-120 microns. In some embodiments, a pocket closure can include apertures less than about 160 microns. - As previously described, in some embodiments, a prosthetic heart valve, such as a prosthetic mitral valve, can be configured to be moved to an inverted configuration for delivery of the prosthetic valve to within a heart of a patient. According to the invention, the outer frame can be moved or inverted relative to the inner frame of the valve. After inverting the outer frame, the prosthetic valve can be inserted into a lumen of a delivery sheath such that the prosthetic valve is moved to a collapsed configuration for delivery of the valve o the heart.
FIGS. 6A-6D andFIGS.7A and 7B illustrate schematically an embodiment of a prosthetic valve that can be moved between a biased expanded configuration for use and an inverted configuration for delivery to a heart. -
FIGS. 6A and 6B are schematic illustrations of a portion of aprosthetic heart valve 300, according to an embodiment, shown in a first configuration and a second configuration respectively, andFIGS. 6C and 6D illustrate the portions of theprosthetic heart valve 300 ofFIGS. 6A and 6B , respectively, shown disposed within a lumen of adelivery sheath 326.FIGS. 7A and 7B illustrate a portion of theprosthetic heart valve 300 ofFIGS. 6A and 6B , respectively, and show length dimensions for the prosthetic heart valve in each of the first configuration and the second configuration. The prosthetic heart valve 300 (also referred to herein as "prosthetic valve" or "valve") can be, for example, a prosthetic mitral valve. Thevalve 300 includes anouter frame 320 and aninner frame 350. Theouter frame 320 and theinner frame 350 are each formed as a tubular structure. Theouter frame 320 and theinner frame 350 can be coupled together atmultiple coupling joints 346 disposed about a perimeter of theinner frame 350 and a perimeter of theouter frame 320 as described in more detail below. Thevalve 300 can also include other features, such as those described above with respect toFIGS. 1-5 . For example, thevalve 300 can include an outer frame assembly, including theouter frame 320, and an inner valve assembly that includes theinner frame 350, that can be formed or configured the same as or similar to the outer frame assemblies and inner valve assemblies described above with respect toFIGS. 1-5 . For illustration purposes, only theinner frame 350 and theouter frame 320 are discussed with respect toFIGS. 6A-7B . The various characteristics and features ofvalve 300 described with respect toFIGS. 6A-7B can apply to any of the prosthetic valves described here. - The
outer frame 320 is configured to have a biased expanded or undeformed shape and can be manipulated and/or deformed (e.g., compressed or constrained) and, when released, return to its original (expanded or undeformed) shape. For example, theouter frame 320 can be formed of materials, such as metals or plastics, that have shape memory properties. With regards to metals, Nitinol® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic. Other shape memory alloys, such as Cu-Zn-Al-Ni alloys, and Cu-Al-Ni alloys, may also be used. Theinner frame 350 can be formed from a laser-cut tube of Nitinol®. Theinner frame 350 can also have a biased expanded or undeformed shape and can be manipulated and/or deformed (e.g., compressed and/or constrained) and, when released, return to its original (expanded or undeformed) shape. Further details regarding theinner frame 350 and theouter frame 320 are described below and with respect tovalve 200 andFIGS. 3-5 . - The
valve 300 can be delivered and deployed within a left atrium of a heart using a variety of different delivery approaches including, for example, a transfemoral delivery approach, as described in the '572 PCT application, or a transatrial approach, as described in the '704 provisional application and the '221 application, or a transjugular approach as described, for example, in the '221 application. As described above, in some situations, such as when delivering a prosthetic valve to the heart via a transfemoral, transjugular or transatrial approach, because of the smaller size of the lumen of the delivery sheath, the size of the prosthetic valve during delivery should be sized accordingly. Thus, it is desirable to have a prosthetic valve that can be reconfigured between a biased expanded configuration for implantation in the heart (e.g., within a native mitral annulus) and a delivery configuration that has a smaller outer perimeter or profile to allow for delivery within the lumen of the delivery sheath. Theprosthetic valve 300 and the embodiments of a prosthetic valve described herein can be constructed and formed to achieve these desired functions and characteristics. - More specifically, the
valve 300 can have a biased expanded configuration (as shown inFIGS. 6A and7A ), an inverted configuration (as shown inFIGS. 6B and7B ), and a compressed or collapsed configuration (as shown inFIGS. 6C and 6D ). The expanded configuration allows thevalve 300 to function when implanted within the heart. Thevalve 300 can be moved to the inverted configuration and the compressed or collapsed configuration for delivery of thevalve 300 to the heart of a patient. - To enable the
valve 300 to be moved to the inverted configuration, theouter frame 320 can be coupled to theinner frame 350 in such a manner to allow theouter frame 320 to move relative to theinner frame 350. More specifically, the coupling joints 346 can couple theouter frame 320 to theinner frame 350 in such a manner to allow theouter frame 320 to be moved relative to theinner frame 350. For example, in some embodiments, the coupling joints 346 can be configured to allow theouter frame 320 to rotate about the coupling joint 346 relative to theinner frame 350. In some embodiments, coupling joints can provide a pivotal coupling between theouter frame 320 and theinner frame 350. In some embodiments, the coupling joints can provide a flexible attachment between theouter frame 320 and theinner frame 350. The coupling joints 346 can be a variety of different types and configurations as described herein with reference to the various embodiments of a prosthetic valve. For example, the coupling joints 146 can include a living hinge, a flexible member, sutures, a suture wrapped through an opening, a pin or tab inserted through an opening or any combinations thereof. - To move the
valve 300 from the expanded configuration (FIG. 6A ) to the inverted configuration (FIG. 6B ), theouter frame 320 is moved to a prolapsed or inverted configuration relative to theinner frame 350, as shown inFIGS. 6B ,6D and7B , by moving (e.g., rotating, pivoting, flexing) theouter frame 320 about the coupling joints 346. The elastic or superelastic structure ofouter frame 320 ofvalve 300 also allows theouter frame 320 to be moved to, and disposed in, the prolapsed or inverted configuration relative to theinner frame 350. To move theouter frame 320 to the inverted configuration relative to theinner frame 350, theouter frame 320 is folded or inverted distally (to the right inFIG. 6B ) relative to theinner frame 350 via the coupling joints 346. As shown inFIGS. 6A and7A , theouter frame 320 is in a first position relative to theinner frame 350 prior to being inverted in which an open or free end portion 316 (also referred to theatrium portion 316 of the outer frame 320) is disposed proximally or to the left of the coupling joints 346 and in the same direction as a free end portion 347 (also referred to as a second end portion of the inner frame) of theinner frame 350. When theouter frame 320 is moved to an inverted configuration (i.e., second positon relative to the inner frame 350), thefree end portion 316 is disposed distally of the coupling joints 346 (or to the right inFIGS. 6B and7B ) and in an opposite direction as thefree end portion 347 of theinner frame 350. Said another way, when thevalve 300 is in a biased expanded configuration (e.g.,FIG. 6A ), the coupling joints 346 are disposed between a first end portion 344 (also referred to as a tether coupling portion) of theinner frame 350 and thefree end portion 316 of theouter frame 320. When thevalve 300 is in the inverted configuration (e.g.,FIG. 6B ) (i.e., theouter frame 320 has been moved to an inverted configuration or position), the coupling joints 346 are disposed between the free end portion orsecond end portion 347 of theinner frame 350 and thefree end portion 316 of theouter frame 320. - When in the inverted configuration, an overall length of the
valve 300 is increased, but a length of theinner frame 350 and a length of theouter frame 320 remains the same (or substantially the same). For example, as shown inFIGS. 7A and 7B an overall length L1 of thevalve 300 in the biased expanded configuration (prior to being inverted as shown inFIG. 7A ) is less than the overall length L2 of thevalve 300 when in the inverted configuration (FIG. 7B ). A length Li of theinner frame 350 and a length LO of theouter frame 320 is substantially the same (or the same) when thevalve 300 is in both the biased expanded configuration and the inverted configuration. In addition, in some instances, depending on the specific configuration of the outer frame, an overall outer perimeter or outer diameter of thevalve 300 can be smaller when thevalve 300 is in the inverted configuration. - With the
valve 300 in the inverted configuration, thevalve 300 can be placed within a lumen of thedelivery sheath 326 for delivery of thevalve 300 to the left atrium of the heart, as shown inFIG. 6D . When placed within the lumen of thedelivery sheath 326, thevalve 300 is moved to the collapsed or compressed configuration in which the outer diameter or outer perimeter of thevalve 300 is reduced. Because thevalve 300 is in the inverted configuration, thevalve 300 is able to be placed within asmaller delivery sheath 326 than would otherwise be possible. For example, for comparison purposes,FIG. 6C illustrates thevalve 300 placed within a lumen of a delivery sheath 326' where thevalve 300 has not been moved to an inverted configuration prior to being disposed within the delivery sheath 326'. As shown inFIG. 6C , an outer diameter of thevalve 300 is reduced, but not to as small of a diameter as for thevalve 100 when placed in adelivery sheath 326 when in the inverted configuration. Thus, inFIG. 6C , thevalve 300 has an overall outer perimeter or outer diameter D1 and inFIG. 6D , thevalve 300 has an overall outer perimeter or outer diameter D2, which is less than D1. - Thus, by disposing the
outer frame 320 in the inverted configuration, thevalve 300 can be collapsed into a smaller overall diameter, i.e. placed in a smallerdiameter delivery sheath 326, than would be possible if thevalve 300 were merely collapsed radially. This is because when the valve is in the biased expanded configuration, theinner frame 350 is nested within an interior of theouter frame 320, and thus theouter frame 320 must be collapsed around theinner frame 350. In some embodiments, theinner frame 350 and the outer frame are disposed concentrically. Whereas in the inverted configuration, theinner frame 350 and theouter frame 320 are arranged axially with respect to each other (i.e., the inner frame is not nested within the outer frame 350), such that theouter frame 320 can be collapsed without needing to accommodate all of the structure of theinner frame 350 inside it. In other words, with theinner frame 350 disposed mostly inside or nested within theouter frame 320, the layers or bulk of the frame structures cannot be compressed to as small a diameter. In addition, if the frames are nested, the structure is less flexible, and therefore, more force is needed to bend the valve, e.g. to pass through tortuous vasculature or to make tight turn in the left atrium after passing through the atrial septum to be properly oriented for insertion into the mitral valve annulus. -
FIGS. 8A and 8B illustrate another embodiment of a prosthetic heart valve that can be delivered and deployed within a left atrium of a heart using a variety of different delivery approaches and which can be moved between an expanded configuration and an inverted configuration as described above forvalve 300. The prosthetic heart valve 400 (also referred to herein as "prosthetic valve" or "valve") can be, for example, a prosthetic mitral valve. Thevalve 400 includes an outer frame assembly including anouter frame 420 and an inner valve assembly including aninner frame 450. Theouter frame 420 and theinner frame 450 are each formed as a tubular structure. Thevalve 400 can also include other features, such as those described above with respect toFIGS. 1A -7D. For illustration purposes, only theinner frame 450 and theouter frame 420 are discussed with respect toFIGS. 8A-8B . It should be understood that the various characteristics and features of the valves described above with respect toFIGS. 1A -7D can apply tovalve 400. - The
outer frame 420 and theinner frame 450 can be coupled together atmultiple coupling joints 446 disposed about a perimeter of theinner frame 450 and a perimeter of theouter frame 420 as described above forvalve 300. The coupling joints 446 can allow theouter frame 420 to be moved relative to theinner frame 450 as described above forvalve 300. For example, theouter frame 420 can be moved between a first position (FIG. 8A ) relative to theinner frame 450 to a second position (FIG. 8B ) relative to theinner frame 450. In the first position, an openfree end portion 416 of theouter frame 420 is disposed in the same direction as an openfree end portion 447 of the inner frame 450 (seeFIG. 8A ). In the second position, theouter frame 420 is inverted relative to theinner frame 450 such that thefree end portion 416 of theouter frame 420 is now disposed in an opposite direction as thefree end portion 447 of the inner frame 450 (seeFIG. 8B ). - As described above for
valves valve 400. Whenvalve 400 is disposed in the annulus of a native heart valve, blood from the atrium can move in and out ofpocket 485. The blood can clot, forming thrombus. To enhance clotting, ingrowth of tissue into the surfaces ofvalve 400, and produce other benefits, thepocket 485 is covered, or enclosed, by a pocket closure 480 (also referred to as an "atrial pocket closure"). Thepocket closure 480 is coupled about a perimeter of theinner frame 450 and a perimeter of theouter frame 420 so as to close-out thepocket 485 at the atrial end of thevalve 400. As shown inFIGS. 8A and 8B thepocket closure 480 is coupled to theinner frame 450 atcoupling portion 482 and toouter frame 420 atcoupling portion 483. Thepocket closure 480 can be formed of one continuous segment or portion of material or can be formed with two or more portions or segments that are coupled together. For example, in some embodiments, thepocket closure 480 can be formed of three portions or segments that are sewn together with sutures or another suitable coupling method. - As described above,
pocket closure 480 can be formed at least in part of any suitable material that is sufficiently porous to allow blood, including particularly red blood cells, to enter thepocket 485, but is not so porous as to allow undesirably large thrombi to leave thepocket 485. For example,pocket closure 480 may be formed at least in part from a material with apertures less than 160 µ, and preferably between 90 µ and 120 µ. In this embodiment, thepocket closure 480 can be formed at least in part from a braided Nitinol material (or a braided tubular Nitinol material) that has the desired porosity. The braided Nitinol material also provides a desired stretchability, flexibility or deformability to accommodate movement of theouter frame 420 between the first positon relative to theinner frame 450 and the second inverted position relative to theinner frame 450. For example, the braided Nitinol material can have shape memory properties that allow thepocket closure 480 to be deformed and/or stretched and then revert back to an original shape or configuration when released. - As shown in
FIG. 8A , when theouter frame 420 is in the first position relative to theinner frame 450, thepocket closure 480 is disposed in a first configuration. As shown inFIG. 8B , when theouter frame 420 is in the second position (i.e., inverted) relative to theinner frame 450, thepocket closure 480 is disposed in a second configuration. More specifically, when theouter frame 420 is moved to the second position in which theouter frame 420 is inverted relative to theinner frame 420, the material and structure of thepocket closure 480 enables thepocket closure 480 to stretch with theouter frame 420 as shown inFIG. 8B . In other words, as shown inFIG. 8B , thepocket closure 480 is stretched or elongated between where it is coupled to the inner frame (i.e., coupling portion 482) and where it is coupled to the outer frame (i.e., coupling portion 483) to a length greater than when theouter frame 420 is in the first positon as shown inFIG. 8A . When theouter frame 420 is moved back to the first position relative to theinner frame 450, thepocket closure 480 can assume its first configuration as shown inFIG. 8A . -
FIGS. 9A and 9B illustrate another embodiment of a prosthetic heart valve that includes a pocket closure that can accommodate the valve being moved between an expanded configuration and an inverted configuration for delivery and deployment of the valve within a left atrium of a heart. The prosthetic heart valve 500 (also referred to herein as "prosthetic valve" or "valve") can be, for example, a prosthetic mitral valve. Thevalve 500 includes an outer valve assembly including anouter frame 520 and an inner valve assembly including aninner frame 550. Theouter frame 520 and theinner frame 550 are each formed as a tubular structure. Thevalve 500 can also include other features, such as those described above with respect toFIGS. 1A -7D. For illustration purposes, only theinner frame 550 and theouter frame 520 are discussed with respect toFIGS. 8A-8B . It should be understood that the various characteristics and features of the valves described above with respect toFIGS. 1A-7D can apply tovalve 500. - As with the previous embodiments, the
outer frame 520 and theinner frame 550 can be coupled together at multiple coupling joints 546 disposed about a perimeter of theinner frame 550 and a perimeter of theouter frame 520 as described above forvalve 300. The coupling joints 546 can allow theouter frame 520 to be moved relative to theinner frame 550 as described above forvalve 300. For example, theouter frame 520 can be moved between a first position (FIG. 9A ) relative to theinner frame 550 to a second position (FIG. 9B ) relative to theinner frame 550. In the first position, an openfree end portion 516 of theouter frame 520 is disposed in the same direction as an openfree end portion 547 of the inner frame 550 (seeFIG. 9A ). In the second position, theouter frame 520 is inverted relative to theinner frame 550 such that thefree end portion 516 of theouter frame 520 is now disposed in an opposite direction as thefree end portion 547 of the inner frame 550 (seeFIG. 9B ). - As described above for
valves valve 500. Whenvalve 500 is disposed in the annulus of a native heart valve, blood from the atrium can move in and out ofpocket 585. The blood can clot, forming thrombus. To enhance clotting, ingrowth of tissue into the surfaces ofvalve 500, and produce other benefits, thepocket 585 is covered, or enclosed, by a pocket closure 580 (also referred to as an "atrial pocket closure"). - In this embodiment, the
pocket closure 580 includes afirst portion 584 coupled to asecond portion 586. As shown in the detail view ofFIG. 9B , thefirst portion 584 includes a first end coupled to theouter frame 520 at a coupling joint 587, and a second end coupled to thesecond portion 586 at acoupling joint 588. Thesecond portion 586 has a first end coupled to thefirst portion 584 at thecoupling joint 588 and a second end coupled to theouter frame 520 at acoupling joint 589. Thus, in this embodiment, thepocket closure 580 is coupled only to theouter frame 520. Thepocket closure 580 can close-out the pocket at the atrial end of thevalve 500. Thefirst portion 584 and thesecond portion 586 of thepocket closure 580 can each be formed as one continuous segment or portion of material or can be formed with two or more portions or segments that are coupled together with for example, sutures or another suitable coupling method. - As described above,
pocket closure 580 can be formed at least in pail of any suitable material that is sufficiently porous to allow blood, including particularly red blood cells, to enter thepocket 585, but is not so porous as to allow undesirably large thrombi to leave thepocket 585. For example,pocket closure 580 may be formed at least in part from a material with apertures less than 160 µ, and preferably between 90 µ and 120 µ. In this embodiment, thefirst portion 584 ofpocket closure 580 can be formed at least in part from a woven or knit polyester fabric with apertures less than 160 µ, and preferably between 90 µ and 120 µ. Thesecond portion 586 ofpocket closure 580 can be formed with a tubular braided Nitinol material as described above forvalve 400 that can provide a desired stretchability or flexibility or deformability to accommodate theouter frame 520 moving between the first positon relative to theinner frame 550 and the second inverted position relative to theinner frame 550. - As shown in
FIG. 9A , when theouter frame 520 is in the first position relative to theinner frame 550, thepocket closure 580 is disposed in a first configuration. As shown inFIG. 9B , when theouter frame 520 is in the second position (i.e., inverted) relative to theinner frame 550, thepocket closure 580 is disposed in a second configuration. More specifically, when theouter frame 520 is moved to the second position in which theouter frame 520 is inverted relative to theinner frame 520, the material and structure of thesecond portion 586 of thepocket closure 580 enables thepocket closure 580 to stretch with theouter frame 520 as shown inFIG. 9B . In other words, as shown inFIG. 9B , thesecond portion 586 ofpocket closure 580 can stretch or elongate between where it is coupled to thefirst portion 584 of the pocket closure 580 (i.e., coupling joint 588) and where it is coupled to the outer frame 520 (i.e., coupling portion 589) to a length greater than when theouter frame 520 is in the first positon as shown inFIG. 9A . Thefirst portion 584 ofpocket closure 580 does not stretch when theouter frame 520 is moved to the second position (i.e., inverted) relative to theinner frame 550. When theouter frame 520 is moved back to the first position relative to theinner frame 550, thepocket closure 580 can assume its first configuration as shown inFIG. 9A . - In some embodiments of a prosthetic heart valve, an additional material layer can be attached to the inner frame in addition to the outer covering described above for previous embodiments (e.g., outer covering 160). The additional material layer can be attached to an inner face or an outer face of the inner frame of the valve. For example, the additional material layer can be attached to an inner face of the inner frame and outside of the leaflets of the valve. In other words, the outer covering can be disposed between the leaflets and the additional material layer, with all three components (leaflets, outer covering and additional material layer) disposed on an inner side of the inner frame of the valve. The additional material layer may be desirable to prevent possible billowing of the belly area of the leaflet. Such billowing can occur, for example, when backpressure that can cause the leaflets to close also applies pressure to the belly area of the leaflets, potentially causing them to bulge out into the pocket area towards the outer frame. The additional material layer can be composed of a variety of different materials.
FIGS. 10A-10C illustrate aprosthetic heart valve 600 that includes such amaterial layer 625. In this embodiment, thematerial layer 625 is disposed as a cylinder that covers aninner frame 650 from abase 622 of theinner frame 650 to a peak oratrium end 624 of theinner frame 650. As shown inFIGS. 10A and 10B , thevalve 600 includesleaflets 670. As shown inFIG. 10C , the cylindrically disposedmaterial layer 625 bridges thepeaks 624 of theframe 650. In an alternative embodiment, the material layer can be configured to follow the shape of the inner frame as shown inFIG. 10D . In this embodiment, a valve 600' includes a material layer 625' that substantially follows or conforms to the shape of theinner frame 650. In other words, the material layer 625' spans between frame portions of theinner frame 650. In some embodiments, the material layers 625, 625' can be, for example, a polyester material.
Claims (18)
- A prosthetic heart valve (400), comprising:an inner frame (450) having an open end portion (447);an outer frame (420) having an open end portion (416) and coupled to the inner frame at its other end such that the outer frame and the inner frame, when the outer frame is in a first position relative to the inner frame, define an annular region (485) between a portion of the inner frame and a portion of the outer frame that is open toward the open end portion of the outer frame and the open end portion of the inner frame, andthe outer frame being movable between the first position relative to the inner frame in which the outer frame is in a biased expanded configuration and a second position relative to the inner frame in which the outer frame is inverted relative to the inner frame; characterised bya stretchable pocket covering (480) coupled to the inner frame and coupled to the outer frame such that an open end of the annular space is covered by the pocket covering between the open end portion of the inner frame and the open end portion of the outer frame,the stretchable pocket covering configured to move between a first configuration in which the pocket covering has a first length when the outer frame is in the first position relative to the inner frame and a second configuration in which the pocket covering has a second length greater
than the first length when the outer frame is in the second position relative to the inner frame. - The prosthetic heart valve (400) of claim 1, wherein the pocket covering (480), the inner frame (450) and outer frame (420) collectively define a pocket (485) in which thrombus can form and be retained when the prosthetic heart valve is disposed within a heart of a patient.
- The prosthetic heart valve (400) of claim 1, wherein when the outer frame (420) is in the first position, the open end portion (416) of the outer frame and the open end portion (447) of the inner frame (450) are each disposed in the same direction, when the outer frame is in the second position, the open end portion of the outer frame is disposed in an opposite direction as the open end portion of the inner frame.
- The prosthetic heart valve (400) of claim 1, wherein the outer frame (420) is coupled to the inner frame (450) at multiple coupling joints (446), the inner frame includes a tether coupling portion opposite the open end portion (447) of the inner frame,when the outer frame is in the first position, the coupling joints are disposed between the open end portion (416) of the outer frame and the tether coupling portion of the inner frame,when the outer frame is in the second position, the coupling joints are disposed between the open end portion of the inner frame and the open end portion of the outer frame.
- The prosthetic heart valve (400) of claim 1, wherein the pocket covering (480) is formed of a material having a porosity that is sufficiently large to allow red blood cells to pass through the pocket closure into the pocket (485) and that is sufficiently small to prevent thrombus formed from the red blood cells to pass through the pocket closure from the pocket.
- The prosthetic heart valve (400) of claim 1, wherein the pocket covering (480) is formed of a braided Nitinol material.
- The prosthetic heart valve (400) of claim 1, wherein the pocket covering (480) is formed of a shape memory material configured to be moved from a biased configuration to an elongated configuration and back to the biased configuration.
- The prosthetic heart valve (400) of claim 1, further comprising:an outer covering (260) disposed on the inner frame (450);leaflets (270) disposed within an interior of the inner frame; anda cylindrical material layer (625) disposed about the outer covering, the cylindrical material layer configured to prevent billowing of a belly area of the leaflets into the annular region.
- The prosthetic heart valve (400) of claim 1, further comprising:an outer covering (260) disposed on the inner frame (450);leaflets (270) disposed within an interior of the inner frame; anda material layer (625) disposed over the outer covering and conforming to the shape of the inner frame, the material layer configured to prevent billowing of a belly area of the leaflets into the annular region.
- A prosthetic heart valve (500), comprising:an inner frame (550) having an open end portion (547);an outer frame (520) having an open end portion (516) and coupled to the inner frame at its other end such that the outer frame and the inner frame, when the outer frame is in a first position relative to the inner frame, define an annular region (585) between a portion of the inner frame and a portion of the outer frame that is open toward the open end portion of the outer frame and the open end portion of the inner frame, andthe outer frame being movable between the first position relative to the inner frame in which the outer frame is in a biased expanded configuration and a second position relative to the inner frame in which the outer frame is inverted relative to the inner frame; characterised bya pocket covering (580) having a first portion (584) coupled to a stretchable second portion (586), the first portion being coupled to the outer frame at a first coupling joint (587), the second portion being coupled to the outer frame at a second coupling joint (589), the pocket covering enclosing the annular space,the pocket covering configured to move between a first configuration in which the second portion of the pocket covering has a first length when the outer frame is in the first position relative to the inner frame and a second configuration in which the second portion of the pocket
covering has a second length greater than the first length when the outer frame is in the second position relative to the inner frame. - The prosthetic heart valve (500) of claim 10, wherein the pocket covering (580) and the outer frame (520) collectively define a pocket (585) in which thrombus can form and be retained when the prosthetic heart valve is disposed within a heart of a patient.
- The prosthetic heart valve (500) of claim 10, wherein when the outer frame (520) is in the first position, the open end portion (516) of the outer frame and the open end portion (547) of the inner frame (550) are each disposed in the same direction, when the outer frame is in the second position, the open end portion of the outer frame is disposed in an opposite direction as the open end portion of the inner frame.
- The prosthetic heart valve (500) of claim 10, wherein the outer frame (520) is coupled to the inner frame (550) at multiple coupling joints (546), the inner frame includes a tether coupling portion opposite the open end portion of the inner frame,when the outer frame is in the first position, the coupling joints are disposed between the open end portion of the outer frame and the tether coupling portion of the inner frame,when the outer frame is in the second position, the coupling joints are disposed between the open end portion of the inner frame and the open end portion of the outer frame.
- The prosthetic heart valve (500) of claim 10, wherein the pocket closure (580) is formed of a material having a porosity that is sufficiently large to allow red blood cells to pass through the pocket closure into the pocket (585) and that is sufficiently small to prevent thrombus formed from the red blood cells to pass through the pocket closure from the pocket.
- The prosthetic heart valve (500) of claim 10, wherein the pocket covering (580) is formed of a braided Nitinol material.
- The prosthetic heart valve (500) of claim 10, wherein the pocket covering (580) is formed of a shape memory material configured to be to be moved from a biased configuration to an elongated configuration and back to the biased configuration.
- The prosthetic heart valve (500) of claim 10, further comprising:an outer covering (260) disposed on the inner frame (550);leaflets (270) disposed within an interior of the inner frame; anda cylindrical material layer (625) disposed about the outer covering, the cylindrical material layer configured to prevent billowing of a belly area of the leaflets into the annular region.
- The prosthetic heart valve (500) of claim 10, further comprising:an outer covering (260) disposed on the inner frame (550);leaflets (270) disposed within an interior of the inner frame; anda material layer (625) disposed over the outer covering and confirming to the shape of the inner frame, the material layer configured to prevent billowing of a belly area of the leaflets into the annular region.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562271606P | 2015-12-28 | 2015-12-28 | |
PCT/US2016/068680 WO2017117109A1 (en) | 2015-12-28 | 2016-12-27 | Atrial pocket closures for prosthetic heart valves |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3397206A1 EP3397206A1 (en) | 2018-11-07 |
EP3397206B1 true EP3397206B1 (en) | 2022-06-08 |
Family
ID=57838510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16828858.7A Active EP3397206B1 (en) | 2015-12-28 | 2016-12-27 | Atrial pocket closures for prosthetic heart valves |
Country Status (7)
Country | Link |
---|---|
US (2) | US10610358B2 (en) |
EP (1) | EP3397206B1 (en) |
JP (1) | JP6795591B2 (en) |
CN (1) | CN108366859B (en) |
AU (1) | AU2016380259B2 (en) |
CA (1) | CA3006010C (en) |
WO (1) | WO2017117109A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11617650B2 (en) | 2012-05-30 | 2023-04-04 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US12036117B2 (en) | 2019-04-10 | 2024-07-16 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007043830A1 (en) | 2007-09-13 | 2009-04-02 | Lozonschi, Lucian, Madison | Heart valve stent |
US8449599B2 (en) * | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
EP3838223A1 (en) | 2009-12-08 | 2021-06-23 | Avalon Medical Ltd. | Device and system for transcatheter mitral valve replacement |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
EP2739214B1 (en) | 2011-08-05 | 2018-10-10 | Cardiovalve Ltd | Percutaneous mitral valve replacement and sealing |
US10376360B2 (en) | 2012-07-27 | 2019-08-13 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic valve apparatus and methods |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US10321986B2 (en) | 2012-12-19 | 2019-06-18 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic heart valve |
US9968443B2 (en) | 2012-12-19 | 2018-05-15 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
EP4166111A1 (en) | 2013-01-24 | 2023-04-19 | Cardiovalve Ltd. | Ventricularly-anchored prosthetic valves |
US11224510B2 (en) | 2013-04-02 | 2022-01-18 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10463489B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10478293B2 (en) | 2013-04-04 | 2019-11-19 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
AU2014342935B2 (en) | 2013-10-28 | 2019-05-16 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US9504565B2 (en) * | 2013-12-06 | 2016-11-29 | W. L. Gore & Associates, Inc. | Asymmetric opening and closing prosthetic valve leaflet |
EP3174502B1 (en) | 2014-07-30 | 2022-04-06 | Cardiovalve Ltd | Apparatus for implantation of an articulatable prosthetic valve |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
WO2016125160A1 (en) | 2015-02-05 | 2016-08-11 | Mitraltech Ltd. | Prosthetic valve with axially-sliding frames |
CA3007660A1 (en) | 2015-12-15 | 2017-06-22 | Neovasc Tiara Inc. | Transseptal delivery system |
EP3397206B1 (en) * | 2015-12-28 | 2022-06-08 | Tendyne Holdings, Inc. | Atrial pocket closures for prosthetic heart valves |
US10433952B2 (en) | 2016-01-29 | 2019-10-08 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
GB201613219D0 (en) | 2016-08-01 | 2016-09-14 | Mitraltech Ltd | Minimally-invasive delivery systems |
CA3031187A1 (en) | 2016-08-10 | 2018-02-15 | Cardiovalve Ltd. | Prosthetic valve with concentric frames |
CN113893064A (en) | 2016-11-21 | 2022-01-07 | 内奥瓦斯克迪亚拉公司 | Methods and systems for rapid retrieval of transcatheter heart valve delivery systems |
EP3583917A4 (en) * | 2017-02-17 | 2020-11-25 | Mitrapex, Inc. | ARTIFICIAL HEART VALVE |
US12064347B2 (en) | 2017-08-03 | 2024-08-20 | Cardiovalve Ltd. | Prosthetic heart valve |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
EP3672530A4 (en) | 2017-08-25 | 2021-04-14 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
WO2019055577A1 (en) | 2017-09-12 | 2019-03-21 | W. L. Gore & Associates, Inc. | Leaflet frame attachment for prosthetic valves |
US10856972B2 (en) | 2017-09-19 | 2020-12-08 | Cardiovalve Ltd. | Prosthetic valve with angularly offset atrial anchoring arms and ventricular anchoring legs |
EP3687452A1 (en) | 2017-09-27 | 2020-08-05 | W. L. Gore & Associates, Inc. | Prosthetic valves with mechanically coupled leaflets |
WO2019067219A1 (en) | 2017-09-27 | 2019-04-04 | W. L. Gore & Associates, Inc. | Prosthetic valve with expandable frame and associated systems and methods |
CN111447890B (en) | 2017-10-13 | 2023-01-31 | W.L.戈尔及同仁股份有限公司 | Telescopic prosthetic valve and delivery system |
US9895226B1 (en) | 2017-10-19 | 2018-02-20 | Mitral Tech Ltd. | Techniques for use with prosthetic valve leaflets |
CA3205219A1 (en) | 2017-10-31 | 2019-05-09 | Edwards Lifesciences Corporation | Medical valve and leaflet promoting tissue ingrowth |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
CN117481869A (en) | 2018-01-25 | 2024-02-02 | 爱德华兹生命科学公司 | Delivery system for assisting in recapture and repositioning of replacement valves after deployment |
US10779946B2 (en) | 2018-09-17 | 2020-09-22 | Cardiovalve Ltd. | Leaflet-testing apparatus |
AU2019374743B2 (en) | 2018-11-08 | 2022-03-03 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
US12121436B2 (en) | 2018-12-04 | 2024-10-22 | Medtronic Bakken Research Center B.V. | Prosthetic heart valve |
CN111437064A (en) * | 2019-01-17 | 2020-07-24 | 上海微创心通医疗科技有限公司 | Prosthetic heart valve |
GB201901887D0 (en) | 2019-02-11 | 2019-04-03 | Cardiovalve Ltd | Device for conditioning ex vivo pericardial tissue |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
CN113747863B (en) | 2019-03-08 | 2024-11-08 | 内奥瓦斯克迪亚拉公司 | Retrievable Prosthesis Delivery System |
CN113811265B (en) | 2019-04-01 | 2024-11-29 | 内奥瓦斯克迪亚拉公司 | Prosthetic valve capable of being deployed in a controlled manner |
US11779742B2 (en) | 2019-05-20 | 2023-10-10 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
EP3986332A4 (en) | 2019-06-20 | 2023-07-19 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
CN110279495B (en) * | 2019-06-25 | 2022-08-26 | 陈翔 | Self-expanding heart valve prosthesis |
EP3881801A1 (en) * | 2020-03-18 | 2021-09-22 | Medtronic Inc. | Improvements in or relating to the delivery and unsheathing of prosthetic heart valves |
WO2022015634A1 (en) * | 2020-07-15 | 2022-01-20 | Tendyne Holdings, Inc. | Tether attachment for mitral valve |
EP4049621A4 (en) * | 2020-12-28 | 2023-02-08 | Shanghai Trulive Medtech Co., Ltd | Artificial valve prosthesis |
CN113057766A (en) * | 2021-05-14 | 2021-07-02 | 上海臻亿医疗科技有限公司 | Heart valve prosthesis device |
Family Cites Families (689)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2697008A (en) | 1953-10-09 | 1954-12-14 | Globe Automatic Sprinkler Co | Sprinkler head |
GB1127325A (en) | 1965-08-23 | 1968-09-18 | Henry Berry | Improved instrument for inserting artificial heart valves |
US3587115A (en) | 1966-05-04 | 1971-06-28 | Donald P Shiley | Prosthetic sutureless heart valves and implant tools therefor |
US3472230A (en) | 1966-12-19 | 1969-10-14 | Fogarty T J | Umbrella catheter |
US3548417A (en) | 1967-09-05 | 1970-12-22 | Ronnie G Kischer | Heart valve having a flexible wall which rotates between open and closed positions |
US3476101A (en) | 1967-12-28 | 1969-11-04 | Texas Instruments Inc | Gas-fired oven |
US3671979A (en) | 1969-09-23 | 1972-06-27 | Univ Utah | Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve |
US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3714671A (en) | 1970-11-30 | 1973-02-06 | Cutter Lab | Tissue-type heart valve with a graft support ring or stent |
US3755823A (en) | 1971-04-23 | 1973-09-04 | Hancock Laboratories Inc | Flexible stent for heart valve |
GB1402255A (en) | 1971-09-24 | 1975-08-06 | Smiths Industries Ltd | Medical or surgical devices of the kind having an inflatable balloon |
US3976079A (en) | 1974-08-01 | 1976-08-24 | Samuels Peter B | Securing devices for sutures |
US4003382A (en) | 1975-07-25 | 1977-01-18 | Ethicon, Inc. | Retention catheter and method of manufacture |
US4035849A (en) | 1975-11-17 | 1977-07-19 | William W. Angell | Heart valve stent and process for preparing a stented heart valve prosthesis |
CA1069652A (en) | 1976-01-09 | 1980-01-15 | Alain F. Carpentier | Supported bioprosthetic heart valve with compliant orifice ring |
US4073438A (en) | 1976-09-03 | 1978-02-14 | Nelson Irrigation Corporation | Sprinkler head |
US4056854A (en) | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
US4297749A (en) | 1977-04-25 | 1981-11-03 | Albany International Corp. | Heart valve prosthesis |
US4265694A (en) | 1978-12-14 | 1981-05-05 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Method of making unitized three leaflet heart valve |
US4222126A (en) | 1978-12-14 | 1980-09-16 | The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare | Unitized three leaflet heart valve |
US4574803A (en) | 1979-01-19 | 1986-03-11 | Karl Storz | Tissue cutter |
GB2056023B (en) | 1979-08-06 | 1983-08-10 | Ross D N Bodnar E | Stent for a cardiac valve |
US4373216A (en) | 1980-10-27 | 1983-02-15 | Hemex, Inc. | Heart valves having edge-guided occluders |
US4339831A (en) | 1981-03-27 | 1982-07-20 | Medtronic, Inc. | Dynamic annulus heart valve and reconstruction ring |
US4470157A (en) | 1981-04-27 | 1984-09-11 | Love Jack W | Tricuspid prosthetic tissue heart valve |
US4345340A (en) | 1981-05-07 | 1982-08-24 | Vascor, Inc. | Stent for mitral/tricuspid heart valve |
US4406022A (en) | 1981-11-16 | 1983-09-27 | Kathryn Roy | Prosthetic valve means for cardiovascular surgery |
DE3365190D1 (en) | 1982-01-20 | 1986-09-18 | Martin Morris Black | Artificial heart valves |
SE445884B (en) | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
IT1212547B (en) | 1982-08-09 | 1989-11-30 | Iorio Domenico | INSTRUMENT FOR SURGICAL USE INTENDED TO MAKE INTERVENTIONS FOR THE IMPLANTATION OF BIOPROTESIS IN HUMAN ORGANS EASIER AND SAFER |
GB8300636D0 (en) | 1983-01-11 | 1983-02-09 | Black M M | Heart valve replacements |
US4535483A (en) | 1983-01-17 | 1985-08-20 | Hemex, Inc. | Suture rings for heart valves |
US4612011A (en) | 1983-07-22 | 1986-09-16 | Hans Kautzky | Central occluder semi-biological heart valve |
US4626255A (en) | 1983-09-23 | 1986-12-02 | Christian Weinhold | Heart valve bioprothesis |
US4585705A (en) | 1983-11-09 | 1986-04-29 | Dow Corning Corporation | Hard organopolysiloxane release coating |
US4787899A (en) | 1983-12-09 | 1988-11-29 | Lazarus Harrison M | Intraluminal graft device, system and method |
US4627436A (en) | 1984-03-01 | 1986-12-09 | Innoventions Biomedical Inc. | Angioplasty catheter and method for use thereof |
US4592340A (en) | 1984-05-02 | 1986-06-03 | Boyles Paul W | Artificial catheter means |
US4979939A (en) | 1984-05-14 | 1990-12-25 | Surgical Systems & Instruments, Inc. | Atherectomy system with a guide wire |
US5007896A (en) | 1988-12-19 | 1991-04-16 | Surgical Systems & Instruments, Inc. | Rotary-catheter for atherectomy |
US4883458A (en) | 1987-02-24 | 1989-11-28 | Surgical Systems & Instruments, Inc. | Atherectomy system and method of using the same |
DE3426300A1 (en) | 1984-07-17 | 1986-01-30 | Doguhan Dr.med. 6000 Frankfurt Baykut | TWO-WAY VALVE AND ITS USE AS A HEART VALVE PROSTHESIS |
DE3442088A1 (en) | 1984-11-17 | 1986-05-28 | Beiersdorf Ag, 2000 Hamburg | HEART VALVE PROSTHESIS |
SU1271508A1 (en) | 1984-11-29 | 1986-11-23 | Горьковский государственный медицинский институт им.С.М.Кирова | Artificial heart valve |
US4759758A (en) | 1984-12-07 | 1988-07-26 | Shlomo Gabbay | Prosthetic heart valve |
US4638886A (en) | 1985-10-21 | 1987-01-27 | Sta-Rite Industries, Inc. | Apparatus for disabling an obstructed lift mechanism |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
DE3640745A1 (en) | 1985-11-30 | 1987-06-04 | Ernst Peter Prof Dr M Strecker | Catheter for producing or extending connections to or between body cavities |
CH672247A5 (en) | 1986-03-06 | 1989-11-15 | Mo Vysshee Tekhnicheskoe Uchil | |
US4878906A (en) | 1986-03-25 | 1989-11-07 | Servetus Partnership | Endoprosthesis for repairing a damaged vessel |
US4777951A (en) | 1986-09-19 | 1988-10-18 | Mansfield Scientific, Inc. | Procedure and catheter instrument for treating patients for aortic stenosis |
US4762128A (en) | 1986-12-09 | 1988-08-09 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
FR2611628B1 (en) | 1987-02-26 | 1990-11-30 | Bendix France | BRAKE CORRECTOR SERVO-LOADED BY A VEHICLE |
US4878495A (en) | 1987-05-15 | 1989-11-07 | Joseph Grayzel | Valvuloplasty device with satellite expansion means |
US4796629A (en) | 1987-06-03 | 1989-01-10 | Joseph Grayzel | Stiffened dilation balloon catheter device |
US4829990A (en) | 1987-06-25 | 1989-05-16 | Thueroff Joachim | Implantable hydraulic penile erector |
US4851001A (en) | 1987-09-17 | 1989-07-25 | Taheri Syde A | Prosthetic valve for a blood vein and an associated method of implantation of the valve |
JPH0624755Y2 (en) | 1987-10-19 | 1994-06-29 | 日産自動車株式会社 | Washer pressure sensor |
US5266073A (en) | 1987-12-08 | 1993-11-30 | Wall W Henry | Angioplasty stent |
US4830117A (en) | 1987-12-24 | 1989-05-16 | Fire Sprinkler Specialties, Inc. | Shut-off device for an automatic sprinkler |
US4960424A (en) | 1988-06-30 | 1990-10-02 | Grooters Ronald K | Method of replacing a defective atrio-ventricular valve with a total atrio-ventricular valve bioprosthesis |
US5032128A (en) | 1988-07-07 | 1991-07-16 | Medtronic, Inc. | Heart valve prosthesis |
DE8815082U1 (en) | 1988-11-29 | 1989-05-18 | Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin | Heart valve prosthesis |
US4856516A (en) | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
US4966604A (en) | 1989-01-23 | 1990-10-30 | Interventional Technologies Inc. | Expandable atherectomy cutter with flexibly bowed blades |
US4994077A (en) | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
EP0474748B1 (en) | 1989-05-31 | 1995-01-25 | Baxter International Inc. | Biological valvular prosthesis |
US5609626A (en) | 1989-05-31 | 1997-03-11 | Baxter International Inc. | Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts |
US4923013A (en) | 1989-08-14 | 1990-05-08 | Gennaro Sergio K De | Fire sprinkler system and automatic shut-off valve therefor |
US5047041A (en) | 1989-08-22 | 1991-09-10 | Samuels Peter B | Surgical apparatus for the excision of vein valves in situ |
US4986830A (en) | 1989-09-22 | 1991-01-22 | Schneider (U.S.A.) Inc. | Valvuloplasty catheter with balloon which remains stable during inflation |
US5035706A (en) | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
US5089015A (en) | 1989-11-28 | 1992-02-18 | Promedica International | Method for implanting unstented xenografts and allografts |
US5591185A (en) | 1989-12-14 | 1997-01-07 | Corneal Contouring Development L.L.C. | Method and apparatus for reprofiling or smoothing the anterior or stromal cornea by scraping |
US5037434A (en) | 1990-04-11 | 1991-08-06 | Carbomedics, Inc. | Bioprosthetic heart valve with elastic commissures |
US5059177A (en) | 1990-04-19 | 1991-10-22 | Cordis Corporation | Triple lumen balloon catheter |
US5411552A (en) | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5085635A (en) | 1990-05-18 | 1992-02-04 | Cragg Andrew H | Valved-tip angiographic catheter |
DK124690D0 (en) | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION |
GB9012716D0 (en) | 1990-06-07 | 1990-08-01 | Frater Robert W M | Mitral heart valve replacements |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5336616A (en) | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
US5152771A (en) | 1990-12-31 | 1992-10-06 | The Board Of Supervisors Of Louisiana State University | Valve cutter for arterial by-pass surgery |
US5282847A (en) | 1991-02-28 | 1994-02-01 | Medtronic, Inc. | Prosthetic vascular grafts with a pleated structure |
JPH05184611A (en) | 1991-03-19 | 1993-07-27 | Kenji Kusuhara | Valvular annulation retaining member and its attaching method |
US5295958A (en) | 1991-04-04 | 1994-03-22 | Shturman Cardiology Systems, Inc. | Method and apparatus for in vivo heart valve decalcification |
US5167628A (en) | 1991-05-02 | 1992-12-01 | Boyles Paul W | Aortic balloon catheter assembly for indirect infusion of the coronary arteries |
US5397351A (en) | 1991-05-13 | 1995-03-14 | Pavcnik; Dusan | Prosthetic valve for percutaneous insertion |
WO1992020303A1 (en) | 1991-05-16 | 1992-11-26 | Mures Cardiovascular Research, Inc. | Cardiac valve |
US5584803A (en) | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US5370685A (en) | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
US5769812A (en) | 1991-07-16 | 1998-06-23 | Heartport, Inc. | System for cardiac procedures |
US5192297A (en) | 1991-12-31 | 1993-03-09 | Medtronic, Inc. | Apparatus and method for placement and implantation of a stent |
US5756476A (en) | 1992-01-14 | 1998-05-26 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of cell proliferation using antisense oligonucleotides |
US5306296A (en) | 1992-08-21 | 1994-04-26 | Medtronic, Inc. | Annuloplasty and suture rings |
CA2127701C (en) | 1992-01-27 | 1999-06-15 | John T. M. Wright | Annuloplasty and suture rings |
US5201880A (en) | 1992-01-27 | 1993-04-13 | Pioneering Technologies, Inc. | Mitral and tricuspid annuloplasty rings |
US5163953A (en) | 1992-02-10 | 1992-11-17 | Vince Dennis J | Toroidal artificial heart valve stent |
US5683448A (en) | 1992-02-21 | 1997-11-04 | Boston Scientific Technology, Inc. | Intraluminal stent and graft |
US5332402A (en) | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
DE4327825C2 (en) | 1992-11-24 | 1996-10-02 | Mannesmann Ag | Throttle check element |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5713951A (en) | 1993-02-22 | 1998-02-03 | Heartport, Inc. | Thoracoscopic valve prosthesis delivery device |
US5972030A (en) | 1993-02-22 | 1999-10-26 | Heartport, Inc. | Less-invasive devices and methods for treatment of cardiac valves |
GB9312666D0 (en) | 1993-06-18 | 1993-08-04 | Vesely Ivan | Bioprostetic heart valve |
US5607462A (en) | 1993-09-24 | 1997-03-04 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-catheter introducer for use therewith |
US5545209A (en) | 1993-09-30 | 1996-08-13 | Texas Petrodet, Inc. | Controlled deployment of a medical device |
US5480424A (en) | 1993-11-01 | 1996-01-02 | Cox; James L. | Heart valve replacement using flexible tubes |
US5609627A (en) | 1994-02-09 | 1997-03-11 | Boston Scientific Technology, Inc. | Method for delivering a bifurcated endoluminal prosthesis |
US5364407A (en) | 1994-03-21 | 1994-11-15 | Poll Wayne L | Laparoscopic suturing system |
US5728068A (en) | 1994-06-14 | 1998-03-17 | Cordis Corporation | Multi-purpose balloon catheter |
US5554185A (en) | 1994-07-18 | 1996-09-10 | Block; Peter C. | Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same |
US5554184A (en) | 1994-07-27 | 1996-09-10 | Machiraju; Venkat R. | Heart valve |
US5833673A (en) | 1994-11-02 | 1998-11-10 | Daig Corporation | Guiding introducer system for use in the treatment of left ventricular tachycardia |
US5904697A (en) | 1995-02-24 | 1999-05-18 | Heartport, Inc. | Devices and methods for performing a vascular anastomosis |
US5683449A (en) | 1995-02-24 | 1997-11-04 | Marcade; Jean Paul | Modular bifurcated intraluminal grafts and methods for delivering and assembling same |
BE1009278A3 (en) | 1995-04-12 | 1997-01-07 | Corvita Europ | Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as. |
US5639274A (en) | 1995-06-02 | 1997-06-17 | Fischell; Robert E. | Integrated catheter system for balloon angioplasty and stent delivery |
US5571175A (en) | 1995-06-07 | 1996-11-05 | St. Jude Medical, Inc. | Suture guard for prosthetic heart valve |
US5716417A (en) | 1995-06-07 | 1998-02-10 | St. Jude Medical, Inc. | Integral supporting structure for bioprosthetic heart valve |
US5697905A (en) | 1995-06-19 | 1997-12-16 | Leo T. d'Ambrosio | Triple-lumen intra-aortic catheter |
US5882341A (en) | 1995-07-07 | 1999-03-16 | Bousquet; Gerald G. | Method of providing a long-lived window through the skin to subcutaneous tissue |
DE19532846A1 (en) | 1995-09-06 | 1997-03-13 | Georg Dr Berg | Valve for use in heart |
US5735842A (en) | 1995-09-11 | 1998-04-07 | St. Jude Medical, Inc. | Low profile manipulators for heart valve prostheses |
US5662704A (en) | 1995-12-01 | 1997-09-02 | Medtronic, Inc. | Physiologic mitral valve bioprosthesis |
DE19546692C2 (en) | 1995-12-14 | 2002-11-07 | Hans-Reiner Figulla | Self-expanding heart valve prosthesis for implantation in the human body via a catheter system |
FR2742994B1 (en) | 1995-12-28 | 1998-04-03 | Sgro Jean-Claude | INTRACORPOREAL LIGHT SURGICAL TREATMENT ASSEMBLY |
US5855602A (en) | 1996-09-09 | 1999-01-05 | Shelhigh, Inc. | Heart valve prosthesis |
US6402780B2 (en) | 1996-02-23 | 2002-06-11 | Cardiovascular Technologies, L.L.C. | Means and method of replacing a heart valve in a minimally invasive manner |
US5716370A (en) | 1996-02-23 | 1998-02-10 | Williamson, Iv; Warren | Means for replacing a heart valve in a minimally invasive manner |
DE69719237T2 (en) | 1996-05-23 | 2003-11-27 | Samsung Electronics Co., Ltd. | Flexible, self-expandable stent and method for its manufacture |
US5855601A (en) | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
US5792179A (en) | 1996-07-16 | 1998-08-11 | Sideris; Eleftherios B. | Retrievable cardiac balloon placement |
US6217585B1 (en) | 1996-08-16 | 2001-04-17 | Converge Medical, Inc. | Mechanical stent and graft delivery system |
AU739710B2 (en) | 1996-08-23 | 2001-10-18 | Boston Scientific Limited | Stent delivery system having stent securement apparatus |
US5968068A (en) | 1996-09-12 | 1999-10-19 | Baxter International Inc. | Endovascular delivery system |
US5968052A (en) | 1996-11-27 | 1999-10-19 | Scimed Life Systems Inc. | Pull back stent delivery system with pistol grip retraction handle |
US5749890A (en) | 1996-12-03 | 1998-05-12 | Shaknovich; Alexander | Method and system for stent placement in ostial lesions |
NL1004827C2 (en) | 1996-12-18 | 1998-06-19 | Surgical Innovations Vof | Device for regulating blood circulation. |
EP0850607A1 (en) | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
US6077214A (en) | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6406420B1 (en) | 1997-01-02 | 2002-06-18 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US6183411B1 (en) | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6045497A (en) | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US5906594A (en) | 1997-01-08 | 1999-05-25 | Symbiosis Corporation | Endoscopic infusion needle having dual distal stops |
GB9701479D0 (en) | 1997-01-24 | 1997-03-12 | Aortech Europ Ltd | Heart valve |
US5957949A (en) | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6206917B1 (en) | 1997-05-02 | 2001-03-27 | St. Jude Medical, Inc. | Differential treatment of prosthetic devices |
US6245102B1 (en) | 1997-05-07 | 2001-06-12 | Iowa-India Investments Company Ltd. | Stent, stent graft and stent valve |
US5855597A (en) | 1997-05-07 | 1999-01-05 | Iowa-India Investments Co. Limited | Stent valve and stent graft for percutaneous surgery |
US5971983A (en) | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US6123725A (en) | 1997-07-11 | 2000-09-26 | A-Med Systems, Inc. | Single port cardiac support apparatus |
WO1999011201A2 (en) | 1997-09-04 | 1999-03-11 | Endocore, Inc. | Artificial chordae replacement |
US6468300B1 (en) | 1997-09-23 | 2002-10-22 | Diseno Y Desarrollo Medico, S.A. De C.V. | Stent covered heterologous tissue |
US5925063A (en) | 1997-09-26 | 1999-07-20 | Khosravi; Farhad | Coiled sheet valve, filter or occlusive device and methods of use |
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
CA2315211A1 (en) | 1997-12-29 | 1999-07-08 | The Cleveland Clinic Foundation | System for minimally invasive insertion of a bioprosthetic heart valve |
US6530952B2 (en) | 1997-12-29 | 2003-03-11 | The Cleveland Clinic Foundation | Bioprosthetic cardiovascular valve system |
EP0935978A1 (en) | 1998-02-16 | 1999-08-18 | Medicorp S.A. | Angioplasty and stent delivery catheter |
US6540693B2 (en) | 1998-03-03 | 2003-04-01 | Senorx, Inc. | Methods and apparatus for securing medical instruments to desired locations in a patients body |
US6174327B1 (en) | 1998-02-27 | 2001-01-16 | Scimed Life Systems, Inc. | Stent deployment apparatus and method |
EP0943300A1 (en) | 1998-03-17 | 1999-09-22 | Medicorp S.A. | Reversible action endoprosthesis delivery device. |
US7060021B1 (en) | 1998-07-23 | 2006-06-13 | Wilk Patent Development Corporation | Method and device for improving cardiac function |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
EP2111800B1 (en) | 1998-07-29 | 2016-06-15 | Edwards Lifesciences AG | Transventricular implant tools and devices |
US6334873B1 (en) | 1998-09-28 | 2002-01-01 | Autogenics | Heart valve having tissue retention with anchors and an outer sheath |
US7128073B1 (en) | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US6066160A (en) | 1998-11-23 | 2000-05-23 | Quickie Llc | Passive knotless suture terminator for use in minimally invasive surgery and to facilitate standard tissue securing |
DE19857887B4 (en) | 1998-12-15 | 2005-05-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anchoring support for a heart valve prosthesis |
FR2788217A1 (en) | 1999-01-12 | 2000-07-13 | Brice Letac | PROSTHETIC VALVE IMPLANTABLE BY CATHETERISM, OR SURGICAL |
US6350277B1 (en) | 1999-01-15 | 2002-02-26 | Scimed Life Systems, Inc. | Stents with temporary retaining bands |
US6896690B1 (en) | 2000-01-27 | 2005-05-24 | Viacor, Inc. | Cardiac valve procedure methods and devices |
US6425916B1 (en) | 1999-02-10 | 2002-07-30 | Michi E. Garrison | Methods and devices for implanting cardiac valves |
DE19907646A1 (en) | 1999-02-23 | 2000-08-24 | Georg Berg | Valve for blood vessels uses flap holders and counterpart holders on stent to latch together in place and all channeled for guide wire. |
US6210408B1 (en) | 1999-02-24 | 2001-04-03 | Scimed Life Systems, Inc. | Guide wire system for RF recanalization of vascular blockages |
US6752813B2 (en) | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
WO2000060995A2 (en) | 1999-04-09 | 2000-10-19 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US6231602B1 (en) | 1999-04-16 | 2001-05-15 | Edwards Lifesciences Corporation | Aortic annuloplasty ring |
US6790229B1 (en) | 1999-05-25 | 2004-09-14 | Eric Berreklouw | Fixing device, in particular for fixing to vascular wall tissue |
US6287339B1 (en) | 1999-05-27 | 2001-09-11 | Sulzer Carbomedics Inc. | Sutureless heart valve prosthesis |
EP1057460A1 (en) | 1999-06-01 | 2000-12-06 | Numed, Inc. | Replacement valve assembly and method of implanting same |
US7416554B2 (en) | 2002-12-11 | 2008-08-26 | Usgi Medical Inc | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US7192442B2 (en) | 1999-06-30 | 2007-03-20 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US6312465B1 (en) | 1999-07-23 | 2001-11-06 | Sulzer Carbomedics Inc. | Heart valve prosthesis with a resiliently deformable retaining member |
US7674222B2 (en) | 1999-08-09 | 2010-03-09 | Cardiokinetix, Inc. | Cardiac device and methods of use thereof |
US6299637B1 (en) | 1999-08-20 | 2001-10-09 | Samuel M. Shaolian | Transluminally implantable venous valve |
IT1307268B1 (en) | 1999-09-30 | 2001-10-30 | Sorin Biomedica Cardio Spa | DEVICE FOR HEART VALVE REPAIR OR REPLACEMENT. |
US6371983B1 (en) | 1999-10-04 | 2002-04-16 | Ernest Lane | Bioprosthetic heart valve |
US8632590B2 (en) | 1999-10-20 | 2014-01-21 | Anulex Technologies, Inc. | Apparatus and methods for the treatment of the intervertebral disc |
US6440164B1 (en) | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
FR2800984B1 (en) | 1999-11-17 | 2001-12-14 | Jacques Seguin | DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY |
FR2815844B1 (en) | 2000-10-31 | 2003-01-17 | Jacques Seguin | TUBULAR SUPPORT FOR THE PERCUTANEOUS POSITIONING OF A REPLACEMENT HEART VALVE |
DE19955490A1 (en) | 1999-11-18 | 2001-06-13 | Thermamed Gmbh | Medical heating device |
US7195641B2 (en) | 1999-11-19 | 2007-03-27 | Advanced Bio Prosthetic Surfaces, Ltd. | Valvular prostheses having metal or pseudometallic construction and methods of manufacture |
US6458153B1 (en) | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
EP1251804B1 (en) | 2000-01-27 | 2008-07-02 | 3F Therapeutics, Inc | Prosthetic heart valve |
PL201632B1 (en) | 2000-01-31 | 2009-04-30 | Cook Biotech | Stent valves and uses of same |
US6989028B2 (en) | 2000-01-31 | 2006-01-24 | Edwards Lifesciences Ag | Medical system and method for remodeling an extravascular tissue structure |
US6402781B1 (en) | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
DE60111184T2 (en) | 2000-02-02 | 2005-10-27 | Robert V. Snyders | ARTIFICIAL HEART FLAP |
US6797002B2 (en) | 2000-02-02 | 2004-09-28 | Paul A. Spence | Heart valve repair apparatus and methods |
DE10007701C2 (en) | 2000-02-19 | 2002-01-31 | Sartorius Gmbh | Display and control unit for a scale |
DE10010074B4 (en) | 2000-02-28 | 2005-04-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device for fastening and anchoring heart valve prostheses |
DE10010073B4 (en) | 2000-02-28 | 2005-12-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anchoring for implantable heart valve prostheses |
ES2440190T3 (en) | 2000-03-03 | 2014-01-28 | C. R. Bard, Inc. | Endoscopic tissue apposition device with multiple suction ports |
WO2001067985A1 (en) | 2000-03-10 | 2001-09-20 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US6537198B1 (en) | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US6454799B1 (en) | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US6610088B1 (en) | 2000-05-03 | 2003-08-26 | Shlomo Gabbay | Biologically covered heart valve prosthesis |
US6951534B2 (en) | 2000-06-13 | 2005-10-04 | Acorn Cardiovascular, Inc. | Cardiac support device |
US6358277B1 (en) | 2000-06-21 | 2002-03-19 | The International Heart Institute Of Montana Foundation | Atrio-ventricular valvular device |
GB2365881A (en) | 2000-07-06 | 2002-02-27 | David Paul Aviram | Interlocking structural panel set |
US20050113798A1 (en) | 2000-07-21 | 2005-05-26 | Slater Charles R. | Methods and apparatus for treating the interior of a blood vessel |
US7510572B2 (en) | 2000-09-12 | 2009-03-31 | Shlomo Gabbay | Implantation system for delivery of a heart valve prosthesis |
WO2002022054A1 (en) | 2000-09-12 | 2002-03-21 | Gabbay S | Valvular prosthesis and method of using same |
US8956407B2 (en) | 2000-09-20 | 2015-02-17 | Mvrx, Inc. | Methods for reshaping a heart valve annulus using a tensioning implant |
US20080091264A1 (en) | 2002-11-26 | 2008-04-17 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US6461382B1 (en) | 2000-09-22 | 2002-10-08 | Edwards Lifesciences Corporation | Flexible heart valve having moveable commissures |
US6602288B1 (en) | 2000-10-05 | 2003-08-05 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template, system and method of use |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6616684B1 (en) | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
DE10049814B4 (en) | 2000-10-09 | 2006-10-19 | Universitätsklinikum Freiburg | Device for supporting surgical procedures within a vessel, in particular for minimally invasive explantation and implantation of heart valves |
DE10049815B4 (en) | 2000-10-09 | 2005-10-13 | Universitätsklinikum Freiburg | Device for local ablation of an aortic valve on the human or animal heart |
DE10049812B4 (en) | 2000-10-09 | 2004-06-03 | Universitätsklinikum Freiburg | Device for filtering out macroscopic particles from the bloodstream during local removal of an aortic valve on the human or animal heart |
DE10049813C1 (en) | 2000-10-09 | 2002-04-18 | Universitaetsklinikum Freiburg | Instrument for the local removal of built-up matter at an aortic valve, in a human or animal heart, is a hollow catheter with a cutting unit at the far end within a closure cap for minimum invasion |
ES2322239T3 (en) | 2000-11-07 | 2009-06-18 | Carag Ag | A DEVICE FOR PLUGGING AN OPENING SUCH AS A WALL OF A HOLLOW OR TUBULAR ORGAN. |
US6482228B1 (en) | 2000-11-14 | 2002-11-19 | Troy R. Norred | Percutaneous aortic valve replacement |
US6974476B2 (en) | 2003-05-05 | 2005-12-13 | Rex Medical, L.P. | Percutaneous aortic valve |
JP4328093B2 (en) | 2000-11-21 | 2009-09-09 | レックス メディカル リミテッド パートナーシップ | Percutaneous aortic valve |
US6976543B1 (en) | 2000-11-22 | 2005-12-20 | Grinnell Corporation | Low pressure, extended coverage, upright fire protection sprinkler |
US6494909B2 (en) | 2000-12-01 | 2002-12-17 | Prodesco, Inc. | Endovascular valve |
WO2002047575A2 (en) | 2000-12-15 | 2002-06-20 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with valve |
US6468660B2 (en) | 2000-12-29 | 2002-10-22 | St. Jude Medical, Inc. | Biocompatible adhesives |
US6810882B2 (en) | 2001-01-30 | 2004-11-02 | Ev3 Santa Rosa, Inc. | Transluminal mitral annuloplasty |
NL1017275C2 (en) | 2001-02-02 | 2002-08-05 | Univ Eindhoven Tech | Heart valve prosthesis has through passage with wall at least partly formed by flexible valve components with free outer ends and movable radially for opening and closing through passage |
US20070027535A1 (en) | 2005-07-28 | 2007-02-01 | Cook Incorporated | Implantable thromboresistant valve |
US8038708B2 (en) | 2001-02-05 | 2011-10-18 | Cook Medical Technologies Llc | Implantable device with remodelable material and covering material |
US7326564B2 (en) | 2001-02-20 | 2008-02-05 | St. Jude Medical, Inc. | Flow system for medical device evaluation and production |
US20020139056A1 (en) | 2001-03-05 | 2002-10-03 | Finnell Lee M. | Fire protection system |
US6488704B1 (en) | 2001-05-07 | 2002-12-03 | Biomed Solutions, Llc | Implantable particle measuring apparatus |
US7374571B2 (en) | 2001-03-23 | 2008-05-20 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of manufacture |
US7556646B2 (en) | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
US6733525B2 (en) | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
CA2441886C (en) | 2001-03-23 | 2009-07-21 | Viacor, Incorporated | Method and apparatus for reducing mitral regurgitation |
US6622730B2 (en) | 2001-03-30 | 2003-09-23 | Myocor, Inc. | Device for marking and aligning positions on the heart |
US20050096498A1 (en) | 2001-04-24 | 2005-05-05 | Houser Russell A. | Sizing and shaping device for treating congestive heart failure |
US20050113810A1 (en) | 2001-04-24 | 2005-05-26 | Houser Russell A. | Shaping suture for treating congestive heart failure |
US20050113811A1 (en) | 2001-04-24 | 2005-05-26 | Houser Russell A. | Method and devices for treating ischemic congestive heart failure |
US6676692B2 (en) | 2001-04-27 | 2004-01-13 | Intek Technology L.L.C. | Apparatus for delivering, repositioning and/or retrieving self-expanding stents |
US20020188170A1 (en) | 2001-04-27 | 2002-12-12 | Santamore William P. | Prevention of myocardial infarction induced ventricular expansion and remodeling |
GB0110551D0 (en) | 2001-04-30 | 2001-06-20 | Angiomed Ag | Self-expanding stent delivery service |
ITMI20011012A1 (en) | 2001-05-17 | 2002-11-17 | Ottavio Alfieri | ANNULAR PROSTHESIS FOR MITRAL VALVE |
US6936067B2 (en) | 2001-05-17 | 2005-08-30 | St. Jude Medical Inc. | Prosthetic heart valve with slit stent |
US6575252B2 (en) | 2001-05-29 | 2003-06-10 | Jeffrey Paul Reed | Sprinkler head deactivating tool |
US20040064014A1 (en) | 2001-05-31 | 2004-04-01 | Melvin David B. | Devices and methods for assisting natural heart function |
US6926732B2 (en) | 2001-06-01 | 2005-08-09 | Ams Research Corporation | Stent delivery device and method |
KR100393548B1 (en) | 2001-06-05 | 2003-08-02 | 주식회사 엠아이텍 | Stent |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
US6648077B2 (en) | 2001-07-12 | 2003-11-18 | Bryan K. Hoffman | Fire extinguishing system |
FR2828263B1 (en) | 2001-08-03 | 2007-05-11 | Philipp Bonhoeffer | DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE |
US20030036698A1 (en) | 2001-08-16 | 2003-02-20 | Robert Kohler | Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts |
US6648921B2 (en) | 2001-10-03 | 2003-11-18 | Ams Research Corporation | Implantable article |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US6726715B2 (en) | 2001-10-23 | 2004-04-27 | Childrens Medical Center Corporation | Fiber-reinforced heart valve prosthesis |
GB0125925D0 (en) | 2001-10-29 | 2001-12-19 | Univ Glasgow | Mitral valve prosthesis |
US7143834B2 (en) | 2001-11-01 | 2006-12-05 | Kevin Michael Dolan | Sprinkler assembly |
US6740105B2 (en) | 2001-11-23 | 2004-05-25 | Mind Guard Ltd. | Expandable delivery appliance particularly for delivering intravascular devices |
US20050177180A1 (en) | 2001-11-28 | 2005-08-11 | Aptus Endosystems, Inc. | Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ |
US7182779B2 (en) | 2001-12-03 | 2007-02-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US6793673B2 (en) | 2002-12-26 | 2004-09-21 | Cardiac Dimensions, Inc. | System and method to effect mitral valve annulus of a heart |
US6908478B2 (en) | 2001-12-05 | 2005-06-21 | Cardiac Dimensions, Inc. | Anchor and pull mitral valve device and method |
US7094246B2 (en) | 2001-12-07 | 2006-08-22 | Abbott Laboratories | Suture trimmer |
US6978176B2 (en) | 2001-12-08 | 2005-12-20 | Lattouf Omar M | Treatment for patient with congestive heart failure |
US20030120340A1 (en) | 2001-12-26 | 2003-06-26 | Jan Liska | Mitral and tricuspid valve repair |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US6854668B2 (en) | 2002-04-29 | 2005-02-15 | Victaulic Company Of America | Extended coverage ordinary hazard sprinkler system |
US6746401B2 (en) | 2002-05-06 | 2004-06-08 | Scimed Life Systems, Inc. | Tissue ablation visualization |
US7141064B2 (en) | 2002-05-08 | 2006-11-28 | Edwards Lifesciences Corporation | Compressed tissue for heart valve leaflets |
AU2003247526A1 (en) | 2002-06-12 | 2003-12-31 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
US20050107811A1 (en) | 2002-06-13 | 2005-05-19 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
JP2005534361A (en) | 2002-06-27 | 2005-11-17 | リーバイン,ロバート,エイ. | Systems and methods for atrioventricular regurgitation and ventricular remodeling reversal |
US20050125012A1 (en) | 2002-06-28 | 2005-06-09 | Houser Russell A. | Hemostatic patch for treating congestive heart failure |
DE10362367B3 (en) | 2002-08-13 | 2022-02-24 | Jenavalve Technology Inc. | Device for anchoring and aligning prosthetic heart valves |
CA2714875C (en) | 2002-08-28 | 2014-01-07 | Heart Leaflet Technologies, Inc. | Method and device for treating diseased valve |
US6875231B2 (en) | 2002-09-11 | 2005-04-05 | 3F Therapeutics, Inc. | Percutaneously deliverable heart valve |
US7137184B2 (en) | 2002-09-20 | 2006-11-21 | Edwards Lifesciences Corporation | Continuous heart valve support frame and method of manufacture |
WO2004032796A2 (en) | 2002-10-10 | 2004-04-22 | The Cleveland Clinic Foundation | Method and apparatus for replacing a mitral valve with a stentless bioprosthetic valve |
US7087064B1 (en) | 2002-10-15 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
US7025285B2 (en) | 2002-10-22 | 2006-04-11 | University Of Florida Research Foundation, Inc. | Fire sprinkler flow control device |
US7247134B2 (en) | 2002-11-12 | 2007-07-24 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7404824B1 (en) | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
US7335213B1 (en) | 2002-11-15 | 2008-02-26 | Abbott Cardiovascular Systems Inc. | Apparatus and methods for heart valve repair |
US6997950B2 (en) | 2003-01-16 | 2006-02-14 | Chawla Surendra K | Valve repair device |
US8157810B2 (en) | 2003-02-26 | 2012-04-17 | Cook Medical Technologies Llc | Prosthesis adapted for placement under external imaging |
US7381210B2 (en) | 2003-03-14 | 2008-06-03 | Edwards Lifesciences Corporation | Mitral valve repair system and method for use |
JP4691017B2 (en) | 2003-03-18 | 2011-06-01 | セント ジュード メディカル インコーポレイテッド | Body tissue remodeling method and apparatus |
US6945996B2 (en) | 2003-04-18 | 2005-09-20 | Sedransk Kyra L | Replacement mitral valve |
US7175656B2 (en) | 2003-04-18 | 2007-02-13 | Alexander Khairkhahan | Percutaneous transcatheter heart valve replacement |
CA2523262C (en) | 2003-04-24 | 2012-01-24 | Cook Incorporated | Artificial valve prosthesis with improved flow dynamics |
US7625399B2 (en) | 2003-04-24 | 2009-12-01 | Cook Incorporated | Intralumenally-implantable frames |
EP1635736A2 (en) | 2003-06-05 | 2006-03-22 | FlowMedica, Inc. | Systems and methods for performing bi-lateral interventions or diagnosis in branched body lumens |
US7316706B2 (en) | 2003-06-20 | 2008-01-08 | Medtronic Vascular, Inc. | Tensioning device, system, and method for treating mitral valve regurgitation |
EP1648346A4 (en) | 2003-06-20 | 2006-10-18 | Medtronic Vascular Inc | Valve annulus reduction system |
WO2005002424A2 (en) | 2003-07-02 | 2005-01-13 | Flexcor, Inc. | Annuloplasty rings and methods for repairing cardiac valves |
US7201772B2 (en) | 2003-07-08 | 2007-04-10 | Ventor Technologies, Ltd. | Fluid flow prosthetic device |
RU2006103367A (en) | 2003-07-08 | 2006-06-27 | Вентор Текнолоджиз Лтд. (Il) | IMPLANTED PROSTHETIC DEVICES, IN PARTICULAR, FOR TRANSARTHERIAL DELIVERY IN TREATMENT OF AORTAL STENOSIS AND METHODS OF IMPLANTING SUCH DEVICES |
US7513867B2 (en) | 2003-07-16 | 2009-04-07 | Kardium, Inc. | Methods and devices for altering blood flow through the left ventricle |
WO2005009285A2 (en) * | 2003-07-21 | 2005-02-03 | The Trustees Of The University Of Pennsylvania | Percutaneous heart valve |
WO2005011535A2 (en) | 2003-07-31 | 2005-02-10 | Cook Incorporated | Prosthetic valve for implantation in a body vessel |
US20060259137A1 (en) | 2003-10-06 | 2006-11-16 | Jason Artof | Minimally invasive valve replacement system |
US10219899B2 (en) | 2004-04-23 | 2019-03-05 | Medtronic 3F Therapeutics, Inc. | Cardiac valve replacement systems |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US20050137686A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical, A Delaware Corporation | Externally expandable heart valve anchor and method |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US7381219B2 (en) * | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7470285B2 (en) | 2004-02-05 | 2008-12-30 | Children's Medical Center Corp. | Transcatheter delivery of a replacement heart valve |
US8206439B2 (en) | 2004-02-23 | 2012-06-26 | International Heart Institute Of Montana Foundation | Internal prosthesis for reconstruction of cardiac geometry |
US20090132035A1 (en) | 2004-02-27 | 2009-05-21 | Roth Alex T | Prosthetic Heart Valves, Support Structures and Systems and Methods for Implanting the Same |
US7785341B2 (en) | 2004-02-27 | 2010-08-31 | Aortx, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US20070073387A1 (en) | 2004-02-27 | 2007-03-29 | Forster David C | Prosthetic Heart Valves, Support Structures And Systems And Methods For Implanting The Same |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
EP3308744B2 (en) | 2004-03-11 | 2023-08-02 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
NL1025830C2 (en) | 2004-03-26 | 2005-02-22 | Eric Berreklouw | Prosthesis e.g. heart valve secured in place by ring with shape memory material anchor, includes anchor temperature control system |
US20060004323A1 (en) | 2004-04-21 | 2006-01-05 | Exploramed Nc1, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
WO2005102015A2 (en) | 2004-04-23 | 2005-11-03 | 3F Therapeutics, Inc. | Implantable prosthetic valve |
ES2407684T3 (en) | 2004-05-05 | 2013-06-13 | Direct Flow Medical, Inc. | Heart valve without stent with support structure formed on site |
US8257394B2 (en) | 2004-05-07 | 2012-09-04 | Usgi Medical, Inc. | Apparatus and methods for positioning and securing anchors |
US7938856B2 (en) | 2004-05-14 | 2011-05-10 | St. Jude Medical, Inc. | Heart valve annuloplasty prosthesis sewing cuffs and methods of making same |
US20050288766A1 (en) | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US20050288783A1 (en) | 2004-06-29 | 2005-12-29 | Emanuel Shaoulian | Methods for treating cardiac valves using magnetic fields |
US7462191B2 (en) | 2004-06-30 | 2008-12-09 | Edwards Lifesciences Pvt, Inc. | Device and method for assisting in the implantation of a prosthetic valve |
US7276078B2 (en) | 2004-06-30 | 2007-10-02 | Edwards Lifesciences Pvt | Paravalvular leak detection, sealing, and prevention |
WO2006002492A1 (en) | 2004-07-06 | 2006-01-12 | Baker Medical Research Institute | Treating valvular insufficiency |
US20060042803A1 (en) | 2004-08-31 | 2006-03-02 | Jeanette M. Gallaher | Sprinkler head shut-off tool |
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
US20070162100A1 (en) | 2006-01-10 | 2007-07-12 | Shlomo Gabbay | System and method for loading implanter with prosthesis |
WO2006055982A2 (en) | 2004-11-22 | 2006-05-26 | Avvrx | Ring-shaped valve prosthesis attachment device |
EP1830928B1 (en) | 2004-11-29 | 2017-01-11 | Phoenix Firefighting Technologies SA | System, in particular, fire-fighting system with valves |
US7211110B2 (en) | 2004-12-09 | 2007-05-01 | Edwards Lifesciences Corporation | Diagnostic kit to assist with heart valve annulus adjustment |
CN101076290B (en) | 2004-12-09 | 2011-11-23 | 铸造品股份有限公司 | Aortic Valve Repair |
IE20050841A1 (en) | 2004-12-15 | 2006-10-04 | Mednua Ltd | A medical device suitable for use in treatment of a valve |
US20060142784A1 (en) | 2004-12-28 | 2006-06-29 | Stavros Kontos | Device and method for suturing internal structures puncture wounds |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
JP4959583B2 (en) | 2005-01-25 | 2012-06-27 | タイコ ヘルスケア グループ リミテッド パートナーシップ | Structure for permanent occlusion of hollow anatomical structures |
EP3539508B1 (en) | 2005-02-07 | 2021-07-28 | Evalve, Inc. | Devices for cardiac valve repair |
WO2011034628A1 (en) | 2005-02-07 | 2011-03-24 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
DK1850796T3 (en) | 2005-02-18 | 2016-01-18 | Cleveland Clinic Foundation | DEVICE FOR REPLACEMENT OF A HEART VALVE |
US8685086B2 (en) | 2006-02-18 | 2014-04-01 | The Cleveland Clinic Foundation | Apparatus and method for replacing a diseased cardiac valve |
US7331991B2 (en) | 2005-02-25 | 2008-02-19 | California Institute Of Technology | Implantable small percutaneous valve and methods of delivery |
US7955385B2 (en) | 2005-02-28 | 2011-06-07 | Medtronic Vascular, Inc. | Device, system, and method for aiding valve annuloplasty |
US7717955B2 (en) | 2005-02-28 | 2010-05-18 | Medtronic, Inc. | Conformable prosthesis for implanting two-piece heart valves and methods for using them |
US7579381B2 (en) | 2005-03-25 | 2009-08-25 | Edwards Lifesciences Corporation | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
WO2006105008A1 (en) | 2005-03-25 | 2006-10-05 | Ample Medical, Inc. | Device, systems, and methods for reshaping a heart valve annulus |
US8062359B2 (en) | 2005-04-06 | 2011-11-22 | Edwards Lifesciences Corporation | Highly flexible heart valve connecting band |
EP1893131A1 (en) | 2005-04-20 | 2008-03-05 | The Cleveland Clinic Foundation | Apparatus and method for replacing a cardiac valve |
SE531468C2 (en) | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
US8333777B2 (en) | 2005-04-22 | 2012-12-18 | Benvenue Medical, Inc. | Catheter-based tissue remodeling devices and methods |
US20060247491A1 (en) | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for heart valve treatment |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US7854762B2 (en) | 2005-05-20 | 2010-12-21 | Mayo Foundation For Medical Education And Research | Devices and methods for reducing cardiac valve regurgitation |
EP1883375B1 (en) | 2005-05-24 | 2016-12-07 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valve |
US9089423B2 (en) * | 2010-05-10 | 2015-07-28 | Hlt, Inc. | Stentless support structure |
US8663312B2 (en) | 2005-05-27 | 2014-03-04 | Hlt, Inc. | Intravascular cuff |
US7500989B2 (en) | 2005-06-03 | 2009-03-10 | Edwards Lifesciences Corp. | Devices and methods for percutaneous repair of the mitral valve via the coronary sinus |
US20060287716A1 (en) | 2005-06-08 | 2006-12-21 | The Cleveland Clinic Foundation | Artificial chordae |
JP4987861B2 (en) | 2005-06-09 | 2012-07-25 | ザユニバーシティー オブ マイアミ | Papillary muscle attachment for left ventricular reduction |
US20090082619A1 (en) | 2005-06-09 | 2009-03-26 | De Marchena Eduardo | Method of treating cardiomyopathy |
US7780723B2 (en) | 2005-06-13 | 2010-08-24 | Edwards Lifesciences Corporation | Heart valve delivery system |
US20080058856A1 (en) | 2005-06-28 | 2008-03-06 | Venkatesh Ramaiah | Non-occluding dilation device |
JP2007011557A (en) | 2005-06-29 | 2007-01-18 | Nissan Motor Co Ltd | Traffic jam detection system, onboard information terminal, information center, and method for detecting traffic jam |
US7931630B2 (en) | 2005-07-05 | 2011-04-26 | C. R. Bard, Inc. | Multi-functional and modular urine collection system |
WO2007009117A1 (en) | 2005-07-13 | 2007-01-18 | Arbor Surgical Technologies, Inc. | Two-piece percutaneous prosthetic heart valves and methods for making and using them |
US7927371B2 (en) | 2005-07-15 | 2011-04-19 | The Cleveland Clinic Foundation | Apparatus and method for reducing cardiac valve regurgitation |
US20090112309A1 (en) | 2005-07-21 | 2009-04-30 | The Florida International University Board Of Trustees | Collapsible Heart Valve with Polymer Leaflets |
EP1933756B1 (en) | 2005-08-19 | 2016-07-20 | CHF Technologies Inc. | Steerable lesion excluding heart implants for congestive heart failure |
US20070078297A1 (en) | 2005-08-31 | 2007-04-05 | Medtronic Vascular, Inc. | Device for Treating Mitral Valve Regurgitation |
US7632304B2 (en) | 2005-09-07 | 2009-12-15 | Rbkpark Llc | Coronary stent |
CA2660892A1 (en) | 2005-09-09 | 2007-03-15 | Edwards Lifesciences Corporation | Device and method for reshaping mitral valve annulus |
US20080188928A1 (en) | 2005-09-16 | 2008-08-07 | Amr Salahieh | Medical device delivery sheath |
US7695510B2 (en) | 2005-10-11 | 2010-04-13 | Medtronic Vascular, Inc. | Annuloplasty device having shape-adjusting tension filaments |
US7275604B1 (en) | 2005-10-12 | 2007-10-02 | Wall Terry M | Multi-zone firewall detection system |
US8167932B2 (en) | 2005-10-18 | 2012-05-01 | Edwards Lifesciences Corporation | Heart valve delivery system with valve catheter |
US8216302B2 (en) | 2005-10-26 | 2012-07-10 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
US7785366B2 (en) | 2005-10-26 | 2010-08-31 | Maurer Christopher W | Mitral spacer |
US9259317B2 (en) | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
US8092525B2 (en) | 2005-10-26 | 2012-01-10 | Cardiosolutions, Inc. | Heart valve implant |
US20070100439A1 (en) | 2005-10-31 | 2007-05-03 | Medtronic Vascular, Inc. | Chordae tendinae restraining ring |
DE102005052628B4 (en) | 2005-11-04 | 2014-06-05 | Jenavalve Technology Inc. | Self-expanding, flexible wire mesh with integrated valvular prosthesis for the transvascular heart valve replacement and a system with such a device and a delivery catheter |
CN2902226Y (en) | 2005-11-09 | 2007-05-23 | 王蓉珍 | Artificial heart stent valve |
CN100584292C (en) | 2005-11-09 | 2010-01-27 | 温宁 | Artificial heart valve with scaffold |
US8764820B2 (en) | 2005-11-16 | 2014-07-01 | Edwards Lifesciences Corporation | Transapical heart valve delivery system and method |
WO2007062320A2 (en) | 2005-11-18 | 2007-05-31 | Innovia, Llc | Trileaflet heart valve |
US20070118151A1 (en) | 2005-11-21 | 2007-05-24 | The Brigham And Women's Hospital, Inc. | Percutaneous cardiac valve repair with adjustable artificial chordae |
US8043368B2 (en) | 2005-11-23 | 2011-10-25 | Traves Dean Crabtree | Methods and apparatus for atrioventricular valve repair |
US7632308B2 (en) | 2005-11-23 | 2009-12-15 | Didier Loulmet | Methods, devices, and kits for treating mitral valve prolapse |
US9034006B2 (en) | 2005-12-01 | 2015-05-19 | Atritech, Inc. | Method and apparatus for retrieving an embolized implant |
US9125742B2 (en) | 2005-12-15 | 2015-09-08 | Georgia Tech Research Foundation | Papillary muscle position control devices, systems, and methods |
EP1959865B1 (en) | 2005-12-15 | 2014-12-10 | The Cleveland Clinic Foundation | Apparatus for treating a regurgitant valve |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US20070185571A1 (en) | 2006-02-06 | 2007-08-09 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant valve |
EP1986735A4 (en) | 2006-02-06 | 2011-06-29 | Northwind Ventures | Systems and methods for volume reduction |
WO2008029296A2 (en) | 2006-02-16 | 2008-03-13 | Endocor Pte Ltd. | Minimally invasive heart valve replacement |
US8147541B2 (en) | 2006-02-27 | 2012-04-03 | Aortx, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
US7635386B1 (en) | 2006-03-07 | 2009-12-22 | University Of Maryland, Baltimore | Methods and devices for performing cardiac valve repair |
GB0604952D0 (en) | 2006-03-13 | 2006-04-19 | Renishaw Plc | A fluid connector for fluid delivery apparatus |
US20070215362A1 (en) | 2006-03-20 | 2007-09-20 | Fire Sprinkler System, Inc. | Fire sprinkler system |
EP2022536A3 (en) | 2006-03-22 | 2009-02-18 | Lubrizol Advanced Materials, Inc. | Fire suppression system |
US20110224678A1 (en) | 2006-03-23 | 2011-09-15 | Shlomo Gabbay | Method and implantation system for implanting a cardiovascular prosthesis |
US7524331B2 (en) | 2006-04-06 | 2009-04-28 | Medtronic Vascular, Inc. | Catheter delivered valve having a barrier to provide an enhanced seal |
WO2007130881A2 (en) | 2006-04-29 | 2007-11-15 | Arbor Surgical Technologies, Inc. | Multiple component prosthetic heart valve assemblies and apparatus and methods for delivering them |
US7343980B2 (en) | 2006-05-04 | 2008-03-18 | The Reliable Automatic Sprinkler Co., Inc. | Enhanced protection extended coverage pendent fire protection sprinkler |
US20070265658A1 (en) | 2006-05-12 | 2007-11-15 | Aga Medical Corporation | Anchoring and tethering system |
WO2007131513A1 (en) | 2006-05-15 | 2007-11-22 | Enovacor Aps | A system and a method for altering the geometry of the heart |
US8932348B2 (en) | 2006-05-18 | 2015-01-13 | Edwards Lifesciences Corporation | Device and method for improving heart valve function |
US8535368B2 (en) | 2006-05-19 | 2013-09-17 | Boston Scientific Scimed, Inc. | Apparatus for loading and delivering a stent |
WO2007149910A2 (en) | 2006-06-20 | 2007-12-27 | Aortx, Inc. | Prosthetic heart valves, support structures and systems and methods for implanting the same |
GB0614445D0 (en) | 2006-07-20 | 2006-08-30 | Ricardo Uk Ltd | Control of selective catalytic reduction |
US8568472B2 (en) | 2006-09-08 | 2013-10-29 | Edwards Lifesciences Corporation | Integrated heart valve delivery system |
US8876894B2 (en) | 2006-09-19 | 2014-11-04 | Medtronic Ventor Technologies Ltd. | Leaflet-sensitive valve fixation member |
FR2906454B1 (en) | 2006-09-28 | 2009-04-10 | Perouse Soc Par Actions Simpli | IMPLANT INTENDED TO BE PLACED IN A BLOOD CIRCULATION CONDUIT. |
US7578842B2 (en) | 2006-10-03 | 2009-08-25 | St. Jude Medical, Inc. | Prosthetic heart valves |
US8029556B2 (en) | 2006-10-04 | 2011-10-04 | Edwards Lifesciences Corporation | Method and apparatus for reshaping a ventricle |
US7422072B2 (en) | 2006-10-06 | 2008-09-09 | Kent Demond Dade | Sprinkler wedge |
US8388680B2 (en) | 2006-10-18 | 2013-03-05 | Guided Delivery Systems, Inc. | Methods and devices for catheter advancement and delivery of substances therethrough |
CN101626682B (en) | 2006-10-27 | 2014-04-16 | 爱德华兹生命科学公司 | Biological tissue for surgical implantation |
DE102006052564B3 (en) | 2006-11-06 | 2007-12-13 | Georg Lutter | Mitral valve stent for surgical implantation and fixation of heart valve prosthesis to heart, has stent clips arranged distally, where one of stent clips forms section that is externally rolled in unfolded condition of stent |
US8460372B2 (en) | 2006-11-07 | 2013-06-11 | Dc Devices, Inc. | Prosthesis for reducing intra-cardiac pressure having an embolic filter |
JP2010508093A (en) | 2006-11-07 | 2010-03-18 | セラマジャー,デイヴィッド,スティーヴン | Apparatus and method for treating heart failure |
DE102006052710A1 (en) | 2006-11-08 | 2008-05-29 | Siemens Ag | Device for investigation and execution of interventions, puncture and injections in body cavities of human or animal body, has catheter with distal end and two lumens partly parallel to each other |
US7655034B2 (en) | 2006-11-14 | 2010-02-02 | Medtronic Vascular, Inc. | Stent-graft with anchoring pins |
JP5238716B2 (en) | 2006-12-19 | 2013-07-17 | セント ジュード メディカル インコーポレイテッド | Prosthetic heart valve with stent structure and tissue leaflet and related methods |
US8236045B2 (en) | 2006-12-22 | 2012-08-07 | Edwards Lifesciences Corporation | Implantable prosthetic valve assembly and method of making the same |
JP5443169B2 (en) | 2007-01-03 | 2014-03-19 | ミトラル・ソリューションズ・インコーポレイテッド | Implantable device for controlling the size and shape of an anatomical structure or lumen |
US9510943B2 (en) | 2007-01-19 | 2016-12-06 | Medtronic, Inc. | Stented heart valve devices and methods for atrioventricular valve replacement |
WO2008089365A2 (en) | 2007-01-19 | 2008-07-24 | The Cleveland Clinic Foundation | Method for implanting a cardiovascular valve |
US8057503B2 (en) | 2007-01-25 | 2011-11-15 | Trinity Health-Michigan | Blood vessel occluder and method of use |
ES2441801T3 (en) | 2007-02-05 | 2014-02-06 | Boston Scientific Limited | Percutaneous valve and supply system |
WO2009024859A2 (en) | 2007-08-21 | 2009-02-26 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US20080195126A1 (en) | 2007-02-14 | 2008-08-14 | Jan Otto Solem | Suture and method for repairing a heart |
AU2008216670B2 (en) | 2007-02-15 | 2013-10-17 | Medtronic, Inc. | Multi-layered stents and methods of implanting |
US8070802B2 (en) * | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
US20080208328A1 (en) * | 2007-02-23 | 2008-08-28 | Endovalve, Inc. | Systems and Methods For Placement of Valve Prosthesis System |
US8900214B2 (en) | 2007-03-30 | 2014-12-02 | Onset Medical Corporation | Expandable trans-septal sheath |
US9138315B2 (en) | 2007-04-13 | 2015-09-22 | Jenavalve Technology Gmbh | Medical device for treating a heart valve insufficiency or stenosis |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8480730B2 (en) | 2007-05-14 | 2013-07-09 | Cardiosolutions, Inc. | Solid construct mitral spacer |
EP2150210B1 (en) | 2007-05-15 | 2016-10-12 | JenaValve Technology, Inc. | Handle for manipulating a catheter tip, catheter system and medical insertion system for inserting a self-expandable heart valve stent |
US20080294247A1 (en) | 2007-05-25 | 2008-11-27 | Medical Entrepreneurs Ii, Inc. | Prosthetic Heart Valve |
EP2698129B1 (en) | 2007-06-04 | 2022-11-09 | St. Jude Medical, LLC | Prosthetic heart valve |
WO2009002548A1 (en) | 2007-06-26 | 2008-12-31 | St. Jude Medical, Inc. | Apparatus and methods for implanting collapsible/expandable prosthetic heart valves |
US20100192402A1 (en) | 2007-07-23 | 2010-08-05 | Daido Sangyo Co., Ltd. | Method of drying printed material and apparatus therefor |
WO2009018372A2 (en) | 2007-07-30 | 2009-02-05 | Glodberg Roger P | Apparatus and method for the treatment of stress urinary incontinence |
US20090216322A1 (en) | 2007-08-10 | 2009-08-27 | Le Le | Adjustable annuloplasty ring and activation system |
WO2009026272A1 (en) | 2007-08-21 | 2009-02-26 | Valvexchange Inc. | Method and apparatus for prosthetic valve removal |
EP3075355A1 (en) | 2007-08-23 | 2016-10-05 | Direct Flow Medical, Inc. | Translumenally implantable heart valve with formed in place support |
EP2192875B1 (en) | 2007-08-24 | 2012-05-02 | St. Jude Medical, Inc. | Prosthetic aortic heart valves |
DE102007043830A1 (en) | 2007-09-13 | 2009-04-02 | Lozonschi, Lucian, Madison | Heart valve stent |
DE102007043831B4 (en) | 2007-09-13 | 2009-07-02 | Lozonschi, Lucian, Madison | catheter |
DE202008018589U1 (en) | 2007-09-26 | 2016-03-14 | St. Jude Medical, Inc. | Foldable heart valve prostheses |
WO2009045334A1 (en) | 2007-09-28 | 2009-04-09 | St. Jude Medical, Inc. | Collapsible/expandable prosthetic heart valves with native calcified leaflet retention features |
US9532868B2 (en) | 2007-09-28 | 2017-01-03 | St. Jude Medical, Inc. | Collapsible-expandable prosthetic heart valves with structures for clamping native tissue |
US20090138079A1 (en) | 2007-10-10 | 2009-05-28 | Vector Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US8043301B2 (en) | 2007-10-12 | 2011-10-25 | Spiration, Inc. | Valve loader method, system, and apparatus |
EP2217153B1 (en) | 2007-10-19 | 2021-03-03 | Ancora Heart, Inc. | Systems for cardiac remodeling |
US8597347B2 (en) | 2007-11-15 | 2013-12-03 | Cardiosolutions, Inc. | Heart regurgitation method and apparatus |
DK3494930T3 (en) | 2007-12-14 | 2020-03-02 | Edwards Lifesciences Corp | Blade attachment frame for a prosthetic flap |
US8357387B2 (en) | 2007-12-21 | 2013-01-22 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
US20090171456A1 (en) | 2007-12-28 | 2009-07-02 | Kveen Graig L | Percutaneous heart valve, system, and method |
JP5591120B2 (en) | 2008-01-16 | 2014-09-17 | セント ジュード メディカル インコーポレイテッド | Collapsible / expandable prosthetic heart valve delivery and retrieval system |
WO2009094188A2 (en) | 2008-01-24 | 2009-07-30 | Medtronic, Inc. | Stents for prosthetic heart valves |
WO2009094500A1 (en) | 2008-01-24 | 2009-07-30 | Medtronic Vascular Inc. | Infundibular reducer device delivery system and related methods |
US7833265B2 (en) | 2008-03-13 | 2010-11-16 | Pacesetter, Inc. | Vascular anchoring system and method |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US20100131057A1 (en) | 2008-04-16 | 2010-05-27 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for aortic valve repair |
EP3967274B1 (en) | 2008-04-23 | 2022-08-24 | Medtronic, Inc. | Stented heart valve devices |
US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
US9061119B2 (en) | 2008-05-09 | 2015-06-23 | Edwards Lifesciences Corporation | Low profile delivery system for transcatheter heart valve |
HUE047259T2 (en) | 2008-06-06 | 2020-04-28 | Edwards Lifesciences Corp | Low profile transcatheter heart valve |
US8323335B2 (en) | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
EP2303384B1 (en) | 2008-06-23 | 2015-08-12 | Lumen Biomedical, Inc. | Embolic protection during percutaneous heart valve replacement and similar procedures |
CA2641297A1 (en) | 2008-07-11 | 2010-01-11 | Richard B. Dorshow | Pyrazine derivatives, methods of use, and methods for preparing same |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US20110224655A1 (en) | 2008-09-11 | 2011-09-15 | Asirvatham Samuel J | Central core multifunctional cardiac devices |
CA2749026C (en) | 2008-09-29 | 2018-01-09 | Impala, Inc. | Heart valve |
EP4321134A3 (en) | 2008-11-21 | 2024-05-01 | Percutaneous Cardiovascular Solutions Pty Limited | Heart valve prosthesis and method |
US8591573B2 (en) | 2008-12-08 | 2013-11-26 | Hector Daniel Barone | Prosthetic valve for intraluminal implantation |
EP2379008B1 (en) | 2008-12-22 | 2021-02-17 | Valtech Cardio, Ltd. | Adjustable annuloplasty devices |
US8147542B2 (en) | 2008-12-22 | 2012-04-03 | Valtech Cardio, Ltd. | Adjustable repair chords and spool mechanism therefor |
US8911494B2 (en) | 2009-05-04 | 2014-12-16 | Valtech Cardio, Ltd. | Deployment techniques for annuloplasty ring |
EP2381852A4 (en) | 2009-01-21 | 2014-06-11 | Tendyne Medical Inc | Apical papillary muscle attachment for left ventricular reduction |
US20100210899A1 (en) | 2009-01-21 | 2010-08-19 | Tendyne Medical, Inc. | Method for percutaneous lateral access to the left ventricle for treatment of mitral insufficiency by papillary muscle alignment |
WO2010093837A2 (en) | 2009-02-11 | 2010-08-19 | Tendyne Medical, Inc. | Percutaneous mitral annular stitch to decrease mitral regurgitation |
US10258471B2 (en) | 2009-02-11 | 2019-04-16 | Vdyne, Llc | Catheter |
US20100217382A1 (en) | 2009-02-25 | 2010-08-26 | Edwards Lifesciences | Mitral valve replacement with atrial anchoring |
BRPI1008902A2 (en) | 2009-02-27 | 2016-03-15 | St Jude Medical | prosthetic heart valve. |
US20100249489A1 (en) | 2009-03-27 | 2010-09-30 | Robert Jarvik | Intraventricular blood pumps anchored by expandable mounting devices |
US9011522B2 (en) | 2009-04-10 | 2015-04-21 | Lon Sutherland ANNEST | Device and method for temporary or permanent suspension of an implantable scaffolding containing an orifice for placement of a prosthetic or bio-prosthetic valve |
EP2810620B1 (en) | 2009-04-15 | 2022-09-14 | Edwards Lifesciences CardiAQ LLC | Vascular implant and delivery system |
US8348998B2 (en) | 2009-06-26 | 2013-01-08 | Edwards Lifesciences Corporation | Unitary quick connect prosthetic heart valve and deployment system and methods |
FR2947716B1 (en) | 2009-07-10 | 2011-09-02 | Cormove | IMPLANT IMPLANT IMPROVED |
US8439970B2 (en) | 2009-07-14 | 2013-05-14 | Edwards Lifesciences Corporation | Transapical delivery system for heart valves |
US8845722B2 (en) | 2009-08-03 | 2014-09-30 | Shlomo Gabbay | Heart valve prosthesis and method of implantation thereof |
US20120130391A1 (en) | 2009-08-06 | 2012-05-24 | Mayo Foundation For Medical Education And Research | Implanting organ ports |
US8979933B2 (en) | 2009-08-06 | 2015-03-17 | Alphatec Spine, Inc. | Stand-alone interbody fixation system |
EP2467104B1 (en) | 2009-08-20 | 2016-11-02 | Cook Medical Technologies LLC | Loading apparatus and system for expandable intraluminal medical devices |
US9730790B2 (en) | 2009-09-29 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Replacement valve and method |
CA3050297A1 (en) * | 2009-11-05 | 2011-05-12 | The Trustees Of The University Of Pennsylvania | Valve prosthesis |
US9539081B2 (en) | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
US20130190861A1 (en) | 2012-01-23 | 2013-07-25 | Tendyne Holdings, Inc. | Prosthetic Valve for Replacing Mitral Valve |
EP3838223A1 (en) | 2009-12-08 | 2021-06-23 | Avalon Medical Ltd. | Device and system for transcatheter mitral valve replacement |
WO2011080588A2 (en) | 2009-12-30 | 2011-07-07 | Vivasure Medical Limited | Closure system and uses thereof |
US8475525B2 (en) | 2010-01-22 | 2013-07-02 | 4Tech Inc. | Tricuspid valve repair using tension |
US9522062B2 (en) | 2010-02-24 | 2016-12-20 | Medtronic Ventor Technologies, Ltd. | Mitral prosthesis and methods for implantation |
AU2011220402B2 (en) | 2010-02-26 | 2016-06-09 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for endoluminal valve creation |
US8795354B2 (en) | 2010-03-05 | 2014-08-05 | Edwards Lifesciences Corporation | Low-profile heart valve and delivery system |
HUE059497T2 (en) | 2010-03-05 | 2022-11-28 | Edwards Lifesciences Corp | Support structures for heart valve prosthesis |
US9480557B2 (en) | 2010-03-25 | 2016-11-01 | Medtronic, Inc. | Stents for prosthetic heart valves |
SE535140C2 (en) | 2010-03-25 | 2012-04-24 | Jan Otto Solem | An implantable device, kit and system for improving cardiac function, including means for generating longitudinal movement of the mitral valve |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US8512401B2 (en) | 2010-04-12 | 2013-08-20 | Medtronic, Inc. | Transcatheter prosthetic heart valve delivery system with funnel recapturing feature and method |
EP2560580B1 (en) | 2010-04-21 | 2019-06-19 | Medtronic Inc. | Prosthetic valve with sealing members |
US9629719B2 (en) | 2010-04-23 | 2017-04-25 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9603708B2 (en) | 2010-05-19 | 2017-03-28 | Dfm, Llc | Low crossing profile delivery catheter for cardiovascular prosthetic implant |
US8790394B2 (en) | 2010-05-24 | 2014-07-29 | Valtech Cardio, Ltd. | Adjustable artificial chordeae tendineae with suture loops |
US20130190860A1 (en) | 2010-06-15 | 2013-07-25 | Mayo Foundation For Medical Education And Research | Percutaneously deliverable valves |
US20130030522A1 (en) | 2010-06-16 | 2013-01-31 | Rowe Stanton J | Devices and methods for heart treatments |
US9795476B2 (en) | 2010-06-17 | 2017-10-24 | St. Jude Medical, Llc | Collapsible heart valve with angled frame |
WO2011163275A2 (en) | 2010-06-21 | 2011-12-29 | Cardiaq Valve Technologies, Inc. | Replacement heart valve |
US8992604B2 (en) | 2010-07-21 | 2015-03-31 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
JP5597309B2 (en) | 2010-07-30 | 2014-10-01 | クック メディカル テクノロジーズ エルエルシー | Prosthesis placement equipment with controlled release and recovery |
US9039759B2 (en) | 2010-08-24 | 2015-05-26 | St. Jude Medical, Cardiology Division, Inc. | Repositioning of prosthetic heart valve and deployment |
AU2011293387A1 (en) | 2010-08-24 | 2013-03-14 | Southern Lights Ventures 2002 Limited | Biomaterials with enhanced properties and devices made therefrom |
JP2013536036A (en) | 2010-08-25 | 2013-09-19 | カーディアペックス リミティッド | Minimally invasive surgery technology |
JP5970458B2 (en) * | 2010-09-01 | 2016-08-17 | ムバルブ・テクノロジーズ・リミテッド | Heart valve support structure |
AU2011302641B2 (en) | 2010-09-17 | 2014-10-02 | St. Jude Medical, Cardiology Division, Inc. | Assembly and method for loading a self-expanding collapsible heart valve |
WO2012040655A2 (en) | 2010-09-23 | 2012-03-29 | Cardiaq Valve Technologies, Inc. | Replacement heart valves, delivery devices and methods |
US10321998B2 (en) | 2010-09-23 | 2019-06-18 | Transmural Systems Llc | Methods and systems for delivering prostheses using rail techniques |
PL3590472T3 (en) | 2010-10-05 | 2021-07-12 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US8663272B2 (en) | 2010-10-07 | 2014-03-04 | Boston Scientific Scimed, Inc. | Biodegradable adhesive film for vascular closure |
JP5995110B2 (en) | 2010-10-21 | 2016-09-21 | メドトロニック,インコーポレイテッド | Intraventricular low profile prosthetic mitral valve |
US9289295B2 (en) | 2010-11-18 | 2016-03-22 | Pavilion Medical Innovations, Llc | Tissue restraining devices and methods of use |
US9579197B2 (en) | 2010-12-15 | 2017-02-28 | Medtronic Vascular, Inc. | Systems and methods for positioning a heart valve using visual markers |
CN103491900B (en) | 2010-12-23 | 2017-03-01 | 托尔福公司 | System for mitral valve repair and replacement |
US20130274874A1 (en) | 2010-12-29 | 2013-10-17 | Children's Medical Center Corporation | Curved fiber arrangement for prosthetic heart valves |
CA2827547A1 (en) | 2011-01-11 | 2012-07-19 | Hans Reiner Figulla | Valve prosthesis for replacing an atrioventricular valve of the heart |
US8845717B2 (en) | 2011-01-28 | 2014-09-30 | Middle Park Medical, Inc. | Coaptation enhancement implant, system, and method |
US8888843B2 (en) | 2011-01-28 | 2014-11-18 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valve regurgitation |
GB2488107B (en) | 2011-02-11 | 2013-03-06 | Cook Medical Technologies Llc | Drive assembly for facilitating deployment of an implantable medical device |
US8454656B2 (en) | 2011-03-01 | 2013-06-04 | Medtronic Ventor Technologies Ltd. | Self-suturing anchors |
US9039713B2 (en) | 2011-05-13 | 2015-05-26 | Merit Medical Systems, Inc. | Releasably attached snare loop retrieval device and method of using the same |
JP5872692B2 (en) | 2011-06-21 | 2016-03-01 | トゥエルヴ, インコーポレイテッド | Artificial therapy device |
WO2013011502A2 (en) | 2011-07-21 | 2013-01-24 | 4Tech Inc. | Method and apparatus for tricuspid valve repair using tension |
US9161837B2 (en) | 2011-07-27 | 2015-10-20 | The Cleveland Clinic Foundation | Apparatus, system, and method for treating a regurgitant heart valve |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
CA2844746C (en) | 2011-08-11 | 2018-02-20 | Tendyne Holdings, Inc. | Improvements for prosthetic valves and related inventions |
US9216076B2 (en) | 2011-09-09 | 2015-12-22 | Endoluminal Sciences Pty. Ltd. | Means for controlled sealing of endovascular devices |
US9011468B2 (en) | 2011-09-13 | 2015-04-21 | Abbott Cardiovascular Systems Inc. | Independent gripper |
US8900295B2 (en) | 2011-09-26 | 2014-12-02 | Edwards Lifesciences Corporation | Prosthetic valve with ventricular tethers |
US20140364942A1 (en) | 2011-09-30 | 2014-12-11 | Jenavalve Technology Gmbh | System and method for loading a stent into a medical delivery system |
US11202704B2 (en) * | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
CN107028685B (en) * | 2011-10-19 | 2019-11-15 | 托尔福公司 | Artificial heart valve film device, artificial mitral valve and related systems and methods |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
EP2591754B1 (en) | 2011-11-10 | 2015-02-25 | Medtentia International Ltd Oy | A device and a method for improving the function of a heart valve |
FR2982763B1 (en) * | 2011-11-17 | 2015-07-17 | Ct Hospitalier Regional Universitaire D Amiens | IMPLANT FOR PLACEMENT IN BLOOD CIRCULATION PASSAGE AND TREATMENT DEVICE THEREFOR |
US9827092B2 (en) | 2011-12-16 | 2017-11-28 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
US9078645B2 (en) | 2011-12-19 | 2015-07-14 | Edwards Lifesciences Corporation | Knotless suture anchoring devices and tools for implants |
US20150011821A1 (en) | 2011-12-21 | 2015-01-08 | The Trustees Of The University Of Pennsylania | Mechanical myocardial restraint device |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
WO2013103612A1 (en) | 2012-01-04 | 2013-07-11 | Tendyne Holdings, Inc. | Improved multi-component cuff designs for transcatheter mitral valve replacement, subvalvular sealing apparatus for transcatheter mitral valves and wire framed leaflet assembly |
US20130184811A1 (en) | 2012-01-13 | 2013-07-18 | Tendyne Holdings, Inc. | Device and Method for Replacing Mitral Valve |
US10420645B2 (en) | 2012-02-15 | 2019-09-24 | Children's Medical Center Corporation | Right ventricular papillary approximation |
US20150094802A1 (en) | 2012-02-28 | 2015-04-02 | Mvalve Technologies Ltd. | Single-ring cardiac valve support |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
AU2013232382B2 (en) | 2012-03-12 | 2018-02-01 | Colorado State University Research Foundation | Glycosaminoglycan and synthetic polymer materials for blood-contacting applications |
EP3508173A1 (en) | 2012-05-16 | 2019-07-10 | Edwards Lifesciences Corporation | Systems for placing a coaptation member between valvular leaflets |
EP2852354B1 (en) * | 2012-05-20 | 2020-05-13 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Prosthetic mitral valve |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US9233015B2 (en) | 2012-06-15 | 2016-01-12 | Trivascular, Inc. | Endovascular delivery system with an improved radiopaque marker scheme |
US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
WO2014022124A1 (en) | 2012-07-28 | 2014-02-06 | Tendyne Holdings, Inc. | Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
WO2014021905A1 (en) | 2012-07-30 | 2014-02-06 | Tendyne Holdings, Inc. | Improved delivery systems and methods for transcatheter prosthetic valves |
US9232995B2 (en) | 2013-01-08 | 2016-01-12 | Medtronic, Inc. | Valve prosthesis and method for delivery |
US9468525B2 (en) | 2012-08-13 | 2016-10-18 | Medtronic, Inc. | Heart valve prosthesis |
US10206775B2 (en) | 2012-08-13 | 2019-02-19 | Medtronic, Inc. | Heart valve prosthesis |
DE102012107465A1 (en) | 2012-08-15 | 2014-05-22 | Pfm Medical Ag | Implantable device for use in the human and / or animal body for replacement of an organ flap |
US20140067048A1 (en) | 2012-09-06 | 2014-03-06 | Edwards Lifesciences Corporation | Heart Valve Sealing Devices |
EP2895111B1 (en) | 2012-09-14 | 2023-08-09 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US9138221B2 (en) | 2012-09-20 | 2015-09-22 | Medos International Sarl | Anti-backup suture anchor |
US9023099B2 (en) | 2012-10-31 | 2015-05-05 | Medtronic Vascular Galway Limited | Prosthetic mitral valve and delivery method |
EP2732796A1 (en) | 2012-11-20 | 2014-05-21 | Nakostech Sarl | Mitral valve replacement system |
US9066801B2 (en) | 2013-01-08 | 2015-06-30 | Medtronic, Inc. | Valve prosthesis and method for delivery |
US9132007B2 (en) | 2013-01-10 | 2015-09-15 | Medtronic CV Luxembourg S.a.r.l. | Anti-paravalvular leakage components for a transcatheter valve prosthesis |
EP4166111A1 (en) | 2013-01-24 | 2023-04-19 | Cardiovalve Ltd. | Ventricularly-anchored prosthetic valves |
US9675451B2 (en) | 2013-02-01 | 2017-06-13 | Medtronic CV Luxembourg S.a.r.l. | Anti-paravalvular leakage component for a transcatheter valve prosthesis |
AU2014211983B2 (en) | 2013-02-04 | 2019-04-18 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US10080657B2 (en) | 2013-03-07 | 2018-09-25 | Cedars-Sinai Medical Center | Catheter based apical approach heart prostheses delivery system |
US8986375B2 (en) | 2013-03-12 | 2015-03-24 | Medtronic, Inc. | Anti-paravalvular leakage component for a transcatheter valve prosthesis |
JP6397887B2 (en) * | 2013-03-15 | 2018-09-26 | トゥエルヴ, インコーポレイテッド | Prosthetic heart valve device, prosthetic mitral valve, and related systems and methods |
CN105142574B (en) | 2013-03-15 | 2017-12-01 | 爱德华兹生命科学公司 | Band valve sustainer pipeline |
US9232998B2 (en) | 2013-03-15 | 2016-01-12 | Cardiosolutions Inc. | Trans-apical implant systems, implants and methods |
US9289297B2 (en) | 2013-03-15 | 2016-03-22 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US20140296972A1 (en) | 2013-04-02 | 2014-10-02 | Tendyne Holdings | Deployment Compensator for Transcatheter Valve Delivery |
US20140296971A1 (en) | 2013-04-02 | 2014-10-02 | Tendyne Holdings | Alignment Device for Asymmetric Transcatheter Valve |
US20140296970A1 (en) | 2013-04-02 | 2014-10-02 | Tendyne Holdings, Inc. | Positioning Tool for Transcatheter Valve Delivery |
US20140296969A1 (en) | 2013-04-02 | 2014-10-02 | Tendyne Holdlings, Inc. | Anterior Leaflet Clip Device for Prosthetic Mitral Valve |
US10463489B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US9486306B2 (en) | 2013-04-02 | 2016-11-08 | Tendyne Holdings, Inc. | Inflatable annular sealing device for prosthetic mitral valve |
WO2014162306A2 (en) | 2013-04-02 | 2014-10-09 | Tendyne Holdings, Inc. | Improved devices and methods for transcatheter prosthetic heart valves |
US20140303718A1 (en) | 2013-04-04 | 2014-10-09 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
US10478293B2 (en) | 2013-04-04 | 2019-11-19 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
FR3004638B1 (en) * | 2013-04-19 | 2015-05-29 | Invalv Lab | IMPLANT, IN PARTICULAR TO BE PLACED IN A CARDIAC AURICULO-VENTRICULAR VALVE, COMPRISING A PROXIMAL ARM SPLITTING SYSTEM |
US10188515B2 (en) | 2013-05-13 | 2019-01-29 | Medtronic Vascular Inc. | Devices and methods for crimping a medical device |
EP2999435B1 (en) | 2013-05-20 | 2022-12-21 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems |
CA2908342C (en) | 2013-05-20 | 2021-11-30 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US20140358224A1 (en) * | 2013-05-30 | 2014-12-04 | Tendyne Holdlings, Inc. | Six cell inner stent device for prosthetic mitral valves |
US9610159B2 (en) | 2013-05-30 | 2017-04-04 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
WO2014203171A1 (en) | 2013-06-17 | 2014-12-24 | Heldman Alan | Prosthetic heart valve with linking element and methods for implanting same |
US20140379076A1 (en) | 2013-06-25 | 2014-12-25 | Tendyne Holdings, Inc. | Halo Wire Fluid Seal Device for Prosthetic Mitral Valves |
EP3415120B1 (en) * | 2013-06-25 | 2022-12-14 | Tendyne Holdings, Inc. | Thrombus management and structural compliance features for prosthetic heart valves |
US20150005874A1 (en) | 2013-06-27 | 2015-01-01 | Tendyne Holdings, Inc. | Atrial Thrombogenic Sealing Pockets for Prosthetic Mitral Valves |
CA2919379C (en) | 2013-08-01 | 2021-03-30 | Tendyne Holdings, Inc. | Epicardial anchor devices and methods |
US20150057705A1 (en) | 2013-08-01 | 2015-02-26 | Tendyne Holdings, Inc. | Pursestring Epicardial Pad Device |
US10195028B2 (en) | 2013-09-10 | 2019-02-05 | Edwards Lifesciences Corporation | Magnetic retaining mechanisms for prosthetic valves |
WO2015038458A1 (en) | 2013-09-12 | 2015-03-19 | St. Jude Medical, Cardiology Division, Inc. | Stent designs for prosthetic heart valves |
WO2015051430A1 (en) | 2013-10-10 | 2015-04-16 | Neves Filho Antonio Francisco | Arrangement applied to supporting element for heart-valve replacement or plasty |
WO2015058039A1 (en) | 2013-10-17 | 2015-04-23 | Robert Vidlund | Apparatus and methods for alignment and deployment of intracardiac devices |
AU2014342935B2 (en) | 2013-10-28 | 2019-05-16 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US9526611B2 (en) | 2013-10-29 | 2016-12-27 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of transcatheter prosthetic valves |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
WO2015063580A2 (en) | 2013-10-30 | 2015-05-07 | 4Tech Inc. | Multiple anchoring-point tension system |
CN104586542B (en) | 2013-10-31 | 2017-01-04 | 上海微创心通医疗科技有限公司 | A kind of apparatus and method that implant is loaded in induction system |
US9889004B2 (en) | 2013-11-19 | 2018-02-13 | St. Jude Medical, Cardiology Division, Inc. | Sealing structures for paravalvular leak protection |
US9848880B2 (en) | 2013-11-20 | 2017-12-26 | James E. Coleman | Adjustable heart valve implant |
WO2015120122A2 (en) * | 2014-02-05 | 2015-08-13 | Robert Vidlund | Apparatus and methods for transfemoral delivery of prosthetic mitral valve |
US10292711B2 (en) | 2014-02-07 | 2019-05-21 | St. Jude Medical, Cardiology Division, Inc. | Mitral valve treatment device having left atrial appendage closure |
US9986993B2 (en) | 2014-02-11 | 2018-06-05 | Tendyne Holdings, Inc. | Adjustable tether and epicardial pad system for prosthetic heart valve |
US20150238729A1 (en) | 2014-02-24 | 2015-08-27 | Mark Lynn Jenson | Cardiac Access Catheter, System, and Method |
CN106068109B (en) | 2014-03-10 | 2019-07-23 | 坦迪尼控股股份有限公司 | Device and method for positioning and monitoring the tether load of prosthetic mitral valve |
EP2918248A1 (en) | 2014-03-11 | 2015-09-16 | Epygon Sasu | An expandable stent-valve and a delivery device |
US10149758B2 (en) | 2014-04-01 | 2018-12-11 | Medtronic, Inc. | System and method of stepped deployment of prosthetic heart valve |
US10321987B2 (en) | 2014-04-23 | 2019-06-18 | Medtronic, Inc. | Paravalvular leak resistant prosthetic heart valve system |
EP3142603B1 (en) * | 2014-05-14 | 2018-03-07 | Sorin Group Italia S.r.l. | Implant device and implantation kit |
WO2015175450A1 (en) * | 2014-05-16 | 2015-11-19 | St. Jude Medical, Cardiology Division, Inc. | Transcatheter valve with paravalvular leak sealing ring |
US20150342717A1 (en) | 2014-05-30 | 2015-12-03 | Michael J. O'Donnell | Temporary valve and filter on guide catheter |
US9532870B2 (en) * | 2014-06-06 | 2017-01-03 | Edwards Lifesciences Corporation | Prosthetic valve for replacing a mitral valve |
US10111749B2 (en) | 2014-06-11 | 2018-10-30 | Medtronic Vascular, Inc. | Prosthetic valve with flow director |
US9974647B2 (en) * | 2014-06-12 | 2018-05-22 | Caisson Interventional, LLC | Two stage anchor and mitral valve assembly |
US9750605B2 (en) * | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
CA2972966C (en) | 2015-01-07 | 2023-01-10 | Tendyne Holdings, Inc. | Prosthetic mitral valves and apparatus and methods for delivery of same |
JP6718459B2 (en) | 2015-02-05 | 2020-07-08 | テンダイン ホールディングス,インコーポレイテッド | Expandable epicardial pad and device and methods of delivery thereof |
US9974651B2 (en) * | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
WO2016125160A1 (en) * | 2015-02-05 | 2016-08-11 | Mitraltech Ltd. | Prosthetic valve with axially-sliding frames |
EP4070763B1 (en) | 2015-04-16 | 2024-10-09 | Tendyne Holdings, Inc. | Apparatus for retrieval of transcathter prosthetic valves |
CA2987441A1 (en) | 2015-06-05 | 2016-12-08 | Tendyne Holdings, Inc. | Apical control of transvascular delivery of prosthetic mitral valve |
US10117744B2 (en) * | 2015-08-26 | 2018-11-06 | Edwards Lifesciences Cardiaq Llc | Replacement heart valves and methods of delivery |
US10327894B2 (en) * | 2015-09-18 | 2019-06-25 | Tendyne Holdings, Inc. | Methods for delivery of prosthetic mitral valves |
CA3005908A1 (en) | 2015-12-03 | 2017-06-08 | Tendyne Holdings, Inc. | Frame features for prosthetic mitral valves |
EP3397206B1 (en) * | 2015-12-28 | 2022-06-08 | Tendyne Holdings, Inc. | Atrial pocket closures for prosthetic heart valves |
US20170209268A1 (en) | 2016-01-27 | 2017-07-27 | Medtronic, Inc. | Systems and methods for repositioning a fully deployed valve assembly |
US10321992B2 (en) * | 2016-02-01 | 2019-06-18 | Medtronic, Inc. | Heart valve prostheses having multiple support arms and methods for percutaneous heart valve replacement |
US10531866B2 (en) * | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US10470877B2 (en) | 2016-05-03 | 2019-11-12 | Tendyne Holdings, Inc. | Apparatus and methods for anterior valve leaflet management |
EP3468480B1 (en) * | 2016-06-13 | 2023-01-11 | Tendyne Holdings, Inc. | Sequential delivery of two-part prosthetic mitral valve |
WO2018005779A1 (en) | 2016-06-30 | 2018-01-04 | Tegels Zachary J | Prosthetic heart valves and apparatus and methods for delivery of same |
WO2018013515A1 (en) | 2016-07-12 | 2018-01-18 | Tendyne Holdings, Inc. | Apparatus and methods for trans-septal retrieval of prosthetic heart valves |
US10350062B2 (en) * | 2016-07-21 | 2019-07-16 | Edwards Lifesciences Corporation | Replacement heart valve prosthesis |
CA3031187A1 (en) * | 2016-08-10 | 2018-02-15 | Cardiovalve Ltd. | Prosthetic valve with concentric frames |
GB201616777D0 (en) * | 2016-10-03 | 2016-11-16 | Univ Southampton | A frame for an implantable medical device and a method of manufacturing a frame for an implantable medical device |
US10441421B2 (en) * | 2016-10-28 | 2019-10-15 | St. Jude Medical, Cardiology Division, Inc. | Prosthetic mitral valve |
CR20190381A (en) * | 2017-01-23 | 2019-09-27 | Cephea Valve Tech Inc | Replacement mitral valves |
EP4209196A1 (en) * | 2017-01-23 | 2023-07-12 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CA3063604A1 (en) * | 2017-05-15 | 2018-11-22 | Hlt, Inc. | Valve sealing tissue and mesh structure |
US10575948B2 (en) * | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US10537426B2 (en) * | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
EP3934583B1 (en) * | 2019-03-05 | 2023-12-13 | Vdyne, Inc. | Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis |
-
2016
- 2016-12-27 EP EP16828858.7A patent/EP3397206B1/en active Active
- 2016-12-27 CN CN201680072656.1A patent/CN108366859B/en active Active
- 2016-12-27 JP JP2018522719A patent/JP6795591B2/en active Active
- 2016-12-27 CA CA3006010A patent/CA3006010C/en active Active
- 2016-12-27 AU AU2016380259A patent/AU2016380259B2/en active Active
- 2016-12-27 WO PCT/US2016/068680 patent/WO2017117109A1/en active Application Filing
-
2018
- 2018-05-30 US US15/992,910 patent/US10610358B2/en active Active
-
2020
- 2020-02-21 US US16/797,033 patent/US11464629B2/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11617650B2 (en) | 2012-05-30 | 2023-04-04 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US12036117B2 (en) | 2019-04-10 | 2024-07-16 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
Also Published As
Publication number | Publication date |
---|---|
JP6795591B2 (en) | 2020-12-02 |
EP3397206A1 (en) | 2018-11-07 |
US20180271653A1 (en) | 2018-09-27 |
US20200188100A1 (en) | 2020-06-18 |
CN108366859A (en) | 2018-08-03 |
AU2016380259A1 (en) | 2018-05-17 |
US10610358B2 (en) | 2020-04-07 |
US11464629B2 (en) | 2022-10-11 |
JP2018538031A (en) | 2018-12-27 |
WO2017117109A1 (en) | 2017-07-06 |
CN108366859B (en) | 2021-02-05 |
AU2016380259B2 (en) | 2020-10-22 |
CA3006010A1 (en) | 2017-07-06 |
CA3006010C (en) | 2023-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3397206B1 (en) | Atrial pocket closures for prosthetic heart valves | |
US11234813B2 (en) | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery | |
EP3383322B1 (en) | Frame features for prosthetic mitral valves | |
EP3415120B1 (en) | Thrombus management and structural compliance features for prosthetic heart valves | |
EP3003219B1 (en) | Structural members for prosthetic mitral valves | |
US12023241B2 (en) | Heart valve frame design with non-uniform struts | |
US20150005874A1 (en) | Atrial Thrombogenic Sealing Pockets for Prosthetic Mitral Valves | |
US20140379076A1 (en) | Halo Wire Fluid Seal Device for Prosthetic Mitral Valves | |
WO2013103612A1 (en) | Improved multi-component cuff designs for transcatheter mitral valve replacement, subvalvular sealing apparatus for transcatheter mitral valves and wire framed leaflet assembly | |
WO2021146515A1 (en) | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery | |
JP7556869B2 (en) | Heart valve frame design with non-uniform struts | |
US20250099240A1 (en) | Reinforcement member for an outer skirt of a prosthetic heart valve |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180627 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20220105 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1496411 Country of ref document: AT Kind code of ref document: T Effective date: 20220615 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602016072742 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220908 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220909 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220908 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1496411 Country of ref document: AT Kind code of ref document: T Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221010 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221008 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602016072742 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
26N | No opposition filed |
Effective date: 20230310 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230623 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20221231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221227 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221227 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20161227 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220608 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20241111 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20241114 Year of fee payment: 9 |